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Thursday, 24 May 
 
 14:00-14:15 Welcome Address 
  Giovanni Spinelli (Director of STEMBIO, Palermo) 
  Valerio Orlando (SIBBM President) 
  Pier Paolo Di Fiore (ABCD President) 
 
Session I »  Environment, Stress & Epigenetics – Chair: Davide Corona (Palermo) 
 
 14:15-14:55 Keynote Lecture: Sergio Pimpinelli (Rome) Environmental stress, transposons and 
evolution 
 14:55-15:20 EMBO YIP Lecture: Fabrizio D’Adda di Fagagna (Milan) Molecular mechanisms of 
cellular senescence 
 15:20-15:45  Stefan Schoeftner (Rome) ncRNAs tune the function of mammalian telomeres 
 15:45-16:00  Fabio Ciccarone (Rome) Poly(ADP-ribosyl)ation acts in DNA demethylation of 
mouse primordial germ cells through DNA-damage independent roles 
 16:00-16:15  Angelo Rosa (Trieste) Structure and dynamics of interphase chromosomes 
 
 16:15-17:45 Coffee break and Poster Session I 
 
 17:45-18:00  Dupriez Vincent (Perkin Elmer) Homogeneous microplate format assays to monitor 
histone modifications in biochemical and cell-based assays 
 18:00-18:15 (Merck presentation) 
 18:15-18:45 Science & Society Talk: Giuseppe Testa (Milan) Reprogramming genomes and 
reframing rights 
 18:45-19:15 Science & Society Talk: Enzo De Simone (Naplese) How (and why) to expose high 
school students to the emerging concepts at the frontiers of molecular biology: five 
years experience with the “Eureka” project 
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Friday, 25 May 
 
Session II » Chromatin Modifications & ncRNA – Chair: Marco Bianchi (Milan) 
 
 9:00-9:40 Keynote Lecture: Marco Bianchi (Milan) HMGB1 and the control of nucleosome 
number 
 9:40-10:05 Armenise-Harvard Talk: Tiziana Bonaldi (Milan) Mass Spectrometry approach 
dissects the proteomic landscape of chromatin functional domains 
 10:05-10:20 Maria Cristina Onorati (Palermo) An RNA memory mechanism to inherit 
epigenetic marks 
 10:20-10:35 Elena Magnani (Busto Arsizio,VA) CDH1 epigenetic regulation: a role for UHRF1 
modulation via promoter associated non-coding RNAs? 
 
 10:35-11:00  Coffee break 
 
 11:00-11:25 Davide Gabellini (Milan) A long non-coding RNA links copy number variation to a 
Polycomb/Trithorax epigenetic switch in FSHD muscular dystrophy 
 11:25-11:40 Francesca Munari (Göttingen, Germany) Molecular basis of hHP1β/nucleosome 
interaction in dependence of histone 3 methylation 
 11:40-11:55 Marco Di Stefano (Trieste) Gene co-regulation and co-localization in human 
chromosome 19: a knowledge-based computational approach 
 11:55-12:15 Progetto Bandiera - Coordinator talk: Giuseppe Macino (Rome) The Italian 
Epigen Project 
 
 12:30-14:00 Lunch break 
 
Session III » Epigenetic Signaling in Development, Differentiation & 
Reprogramming – Chair: Giovanni Spinelli  (Palermo) 
 
 14:00-14:40 EMBO ABCD Lecture: Maria Pia Cosma (Barcelona, Spain) Wnt signalling and the 
reprogramming of cell fate to pluripotency 
 14:40-15:05 Michelangelo Cordenonsi (Padua) The Hippo transducer TAZ confers cancer stem 
cell traits on breast cancer cells downstream of epithelial-to-mesenchymal 
transition and the deregulation of the cell polarity determinant Scribble 
 15:05-15:30 Valerio Orlando (Rome) Epigenetic control of Repetitive Elements mobilization 
contributes to cell differentiation and disease 
 15:30-15:45 Cecilia Battistelli (Rome) MyoD regulates p57kip2 expression by interacting with a 
distant cis-element and modifying a higher-order chromatin structure 
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 15:45-16:00 Paola Tognini (Pisa) Experience-dependent expression of miR132 regulates ocular 
dominance plasticity 
 16:00-16:20 Editor Talk: David del Alamo (The EMBO Journal, Heidelberg, Germany) Behind 
the scenes of scientific publication 
 
 16:20-17:45 Coffee break and Poster Session II 
 
Session IV » Functional Epigenomics – Chair: Valerio Orlando (Rome) 
 
 17:45-18:25 EMBO Lecture: Amos Tanay (Rehovot, Israel) Hi-C and the hierarchical domain 
chromosomal topology 
 18:25-18:40 Raffaele Giancarlo (Palermo) The chromatin organization of an eukaryotic genome: 
sequence specific + statistical=combinatorial 
 18:40-20:00 General SIBBM Society & Board Meeting (SIBBM members only) 
 
 20:30 Social dinner (tickets available at SIBBM registration desk) 
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Saturday, 26 May 
 
Session V » Epigenetics, Disease & Regenerative Medicine 
  Chair: Irene Bozzoni (Rome) 
 
 9:00-9:40 Keynote Lecture: Irene Bozzoni (Rome) The increase in complexity of the RNA 
landscape: new functions of non coding RNAs 
 9:40-9:55 Anna Garbelli (Pavia) A new paradigm for HIV-1 chemotherapy: targeting the host 
cell viral cofactor DDX3 
 9:55-10:10 Federica Lo Sardo (Rome) PcG-mediated higher order chromatin structures 
modulate replication programs at the Drosophila BX-C 
 10:10-10:25 Anna Comel (Trieste) Dissecting the tumor suppression activity of the 
bromodomain containing protein BRD7 
 10:25-10:40 Italia Anna Asteriti (Rome) A high-throughput imaging approach to study Aurora-
A inhibition in human cell 
 
 10:40-11:00  Coffee break 
 
 11:00-11:25 Gabriella Minchiotti (Naples) Molecular control of satellite cell lineage progression 
and muscle regeneration through a novel Cripto -dependent mechanism 
 11:25-11:50 Vania Broccoli (Milan) Reprogramming cellular identity for in vitro modeling and 
replacement therapy of Parkinson's disease 
 
 12:00-12:30  Chiara D'Onofrio "Giovani" Award (prize to be awarded to the best 




in chronological order of presentation 
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Environmental stress, transposons and evolution 
S. Pimpinelli 
Dept Biology and e Biotechnology  "Charles Darwin", Sapienza Univ., Rome, Italy 
After Darwin’s book on the origin of species by natural selection, the theory epoused by his 
predecessor Lamarck was never completely abandoned. To explain, some of the apparent 
Lamarckian-like phenomena in a Darwinian sense, Waddington elaborated the “canalization and 
assimilation” concepts (Waddington, Nature, 1959). He hypothesised the existence of a cryptic 
genetic variation that is maintained hidden due to the robustness of the developmental process 
that he indicated as “canalization”. If an environmental stress is strong enough to overcome this 
robustness, cryptic genetic variants can be expressed and become heritable by an “assimilation” 
process. 
In past years, it has been observed that in fliesand plants, when the activity of Hsp90 is reduced, 
a wide spectrum of phenotypic variants is induced (Rutherford and Lindquist, Nature, 1998; 
Queitsch et al., Nature, 2002). The interpretation was that Hsp90 is a "capacitor" of 
morphological evolution and buffers a cryptic genetic variation that accumulates in neutral 
conditions. 
However, an other study by Specchia et al. (Nature, 2010) has suggested that Hsp90, rather than 
functioning as a capacitor, instead acts as a "mutator" through impairment of RNAi silencing. It 
has been demonstrated that Hsp90 is involved in repression of transcription and mobilization of 
transposable elements. The reduction of Hsp90 causes stress response-like activation and 
transposition of mobile elements causing phenotypic variants. 
This observation, suggests a mechanism for rapid evolutionary changes: the environmental 
changes play a direct active role on evolution of genomes by the induction of genetic variability, 
by means of transposons, and thus allowing for the possibility of selection of more adapted 
genotypes along with their more adaptive stress-response, i.e. transposons may also make 
evolvability evolvable. 
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ncRNAs tune the function of mammalian telomeres 
S. Schoeftner 
Istituto Nazionale Tumori, Regina Elena (IFO), Rome, Italy 
Telomeres are nucleoprotein structures that protect chromosome ends from DNA repair 
mechanisms. Telomere function is essential for genomic stability and controlled by a delicate 
equilibrium of the protein complex shelterin, telomerase and the recently discovered non-
coding RNA TERRA. Critical telomere shortening in the absence of telomerase triggers 
senescence and apoptosis. In line with this, re-activation of telomerase activity or unleashing 
telomere-recombination is a central step in tumorigenesis. Consequently, identifying 
mechanisms that allow interfering with telomere maintenance is a promising approach to limit 
cancer cell proliferation. 
Non-coding RNAs (ncRNAs) such as miRNAs have been demonstrated to be critically involved 
into tumorsuppression and oncogenesis. However non-coding RNAs that control telomere 
function and homeostasis by regulating the expression of shelterin components are unknown. 
By identifying and characterizing “telo-miRNAs” we wish to uncover new mechanisms of 
telomere regulation with high relevance to human cancer and organismal ageing. 
  SIBBM Seminar | Frontiers in Molecular Biology 
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Poly(ADP-ribosyl)ation acts in DNA demethylation of mouse primordial germ cells 
through DNA-damage independent roles 
F. Ciccarone1,2, F.G. Klinger3, A. Catizone4, R. Calabrese1,2, M. Zampieri1,2, M.G. Bacalini1,2,  
M. De Felici3, P. Caiafa1,2 
1Dept of Cellular Biotechnologies and Hematology, Sapienza Univ. of Rome, Italy 
2Pasteur Institute-Fondazione Cenci Bolognetti, Rome, Italy 
3Dept of Public Health and Cell Biology, Univ. of Rome Tor Vergata, Italy 
4Dept of Anatomy, Histology, Forensic Medicine and Orthopedics, Sapienza Univ. of Rome, Italy 
Poly(ADP-ribosyl)ation regulates chromatin structure and transcription driving epigenetic 
events. In particular, Parp1 is able to directly influence DNA methylation patterns controlling 
transcription and activity of Dnmt1. Here, we show that ADP-ribose polymers levels and Parp1 
expression are noticeably high in mouse primordial germ cells (PGCs) when the bulk of DNA 
demethylation occurs during germline epigenetic reprogramming in the embryo. Notably, Parp1 
activity is stimulated in PGCs also before its participation in the DNA damage response 
associated with active DNA demethylation. We demonstrate that PARP inhibition impairs both 
genome-wide and locus-specific DNA methylation erasure in PGCs. Besides acting as DNA 
break sensor during active DNA demethylation, Parp1 may control the activity of Dnmt1, which 
is still expressed in PGCs undergoing reprogramming. Moreover, we evidence that impairment 
of PARP activity causes a significant reduction of the expression of genes coding for Tet 
hydroxylases involved in active DNA demethylation. Taken together these results demonstrate 
new and adjuvant roles of poly(ADP-ribosyl)ation during germline DNA demethylation and 
suggest its possible more general involvement in genome reprogramming.   
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Structure and dynamics of interphase chromosomes 
A. Rosa1, R. Everaers2 
1Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy 
2Ecole Normale Supérieure de Lyon, Lyon, France 
During interphase chromosomes decondense, but fluorescent in situ hybridization experiments 
reveal the existence of distinct territories occupied by individual chromosomes inside the nuclei 
of most eukaryotic cells. We use computer simulations to show that the existence and stability of 
territories is a kinetic effect that can be explained without invoking an underlying nuclear 
scaffold or protein-mediated interactions between DNA sequences. In particular, we show that 
the experimentally observed territory shapes and spatial distances between marked chromosome 
sites for human, fruit-fly, and budding yeast chromosomes can be reproduced by a parameter-
free minimal model of decondensing chromosomes. 
Our results suggest that the observed interphase structure and dynamics are due to generic 
polymer effects: confined Brownian motion conserving the local topological state of long chain 
molecules and segregation of mutually unentangled chains due to topological constraints. 
References: 
1) A. Rosa, R. Everaers, Plos Comput. Biol. 4, e1000153 (2008) 
2) A. Rosa et al., Biophys. J. 98, 2410 (2010) 
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Reprogramming genomes and reframing rights 
G. Testa 
European Institute of Oncology, Milan, Italy 
In this work I trace the mutual shaping between the emergence of cell technologies that 
reprogram our bodily lineages and the legal and political settlements that reframe rights and 
institutions around their circulation. The ability to extract cells from organisms and grow them 
in vitro is a foundational resource in the life sciences, aiming at modeling, reproducing or 
managing living processes under increasingly defined conditions. More recently, the emerging 
field of systems biology has been attempting a new modeling leap, with the ambition to derive in 
silico models that are mostly generated from cells grown in vitro and whose interpretation is 
related back to living functions. This triangulation between in vivo, in vitro and in silico is now 
receiving a paradigm-shift with the advent of cell fate reprogramming induced by transcription 
factors, translating into the ability to generate, from any individual, a virtually limitless supply of 
cells growing in vitro into possibly any desired lineage. Modeling ambitions are therefore 
contemplating new heights, as testified by ‘disease in a dish’ approaches being applied to model 
also complex behavioral traits. Yet, the increasing ability to manipulate cell fate has opened a 
space of experimentation that is not only epistemic but also explicitly social. For, as cells are 
sourced from bodies to model various aspects of the human condition in their circulation 
through academic labs, companies, biobanks and hospitals, they become key resources for the 
operation of current life sciences in their molecular gaze on humanness. And as such they 
become invested with the political, moral and economic rationalities that inspire their 
generation, thus becoming structuring elements of a normative order on the human condition 
and its underlying dichotomies in knowledge-intensive societies: normal versus pathological; 
natural versus artificial; private versus public; individual versus collective; expert versus lay. 
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HMGB1 and the control of nucleosome number 
B. Celona1, A. Weiner2, F. Di Felice3, F. Mancuso4, E. Cesarini3, R.L. Rossi5, L.Gregory6, D. Baban6, 
G. Rossetti5, M. Pagani5, Giovanni Pietrogrande1, T. Bonaldi4,  I. Ragoussis6, N. Friedman2,  
G. Camilloni3, A. Agresti1, M.E. Bianchi1 
1San Raffaele Univ. and Research Institute, Milan 
2Hebrew Univ., Jerusalem 
3Univ. di Roma La Sapienza, Rome 
4IFOM-IEO Campus, Milan 
5Istituto Nazionale Genetica Molecolare, Milan 
6Univ. of Oxford, Oxford 
It is currently assumed that the number of nucleosomes is ﬁxed, and proportional to the 
quantity of DNA to be packaged. The location of some nucleosomes may depend on the 
sequence being packaged (or its propensity to being bent). Strongly positioned nucleosomes may 
determine the "statistical positioning" of the remaining nucleosomes, like some well-parked cars 
guide the parking of other cars in a parking lot. Nucleome position determines the accessibility 
of DNA, and controls gene expression. 
We show that High Mobility Group Box 1 protein (HMGB1) facilitates nucleosome assembly. 
Mammalian cells lacking HMGB1 contain a reduced amount of core, linker and variant histones, 
and a correspondingly reduced number of nucleosomes. Yeast nhp6 mutants lacking Nhp6a and 
–b proteins, which are related to HMGB1, also have a reduced amount of histones and fewer 
nucleosomes. Nucleosome limitation in both mammalian and yeast cells increases the sensitivity 
of DNA to damage, increases transcription globally, and affects the relative expression of about 
10% of genes. In yeast nhp6 cells the loss of more than one nucleosome in four does not affect 
the location of nucleosomes and their spacing, but nucleosomal occupancy. The decrease in 
nucleosomal occupancy is non-uniform; nucleosomes on sites with low propensity to 
occupation are disproportionately lost in nucleosome-depleted cells. 
We disprove the notion that the number of nucleosomes is ﬁxed and set by default. At least in 
yeast, variation in nucleosome number affects nucleosomal occupancy (but not location), both 
genomewide and gene-speciﬁcally, and constitutes a novel layer of epigenetic regulation. 
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A combined ChIP - Mass Spectrometry approach dissects the proteomic landscape of 
chromatin functional domains  
M. Soldi and T. Bonaldi* 
European Institute of Oncology (IEO), Dept of Experimental Oncology, c/o IFOM-IEO Campus, Milan, Italy 
Chromatin is a highly dynamic well organized nucleoprotein complex of DNA and proteins that 
controls various DNA-dependent processes. Chromatin dynamicity is regulated by various 
chromatin associated proteins, post-translational modifications of histones and DNA 
methylation; however, until now the characterization of the proteomic component of chromatin 
at specific regions has been held back by the difficulty in enriching such domains at purity and 
amount sufficient for the in depth analysis of proteins and hPTMs associated in a combinatorial 
fashion. We describe here the optimization of a method for a preparative-ChIP to isolate specific 
functional chromatin regions and the subsequent mass spectrometric analysis to identify their 
interactome and hPTMs patterns. Our PROMIC (Proteomic Mapping of Immunopurified 
Chromatin) approach leads to the characterization of transcriptionally silent and active 
chromatin regions, marked by H3K9me3 and H3K4me3, respectively and expands the arsenal of 
analytical strategies aiming at understanding how hPTMs combinations and their specific 
interactors mediate the locus-specific structural-function of chromatin.  
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An RNA memory mechanism to inherit epigenetic marks  
M.C. Onorati1, W. Arancio2, D.F.V. Corona1 
1STEMBIO Dept Dulbecco Telethon Institute c/o Univ. of Palermo 
2Endocrinologia e malattie metaboliche Azienda Universitaria Policlinico PAolo Giaccone, Palermo 
A central question in epigenetics is to understand how, terminally differentiated daughter cells 
can inherit complex patterns of chromatin modifications from their mother cell. Even if several 
mechanisms have been hypothized to explain the establishment and maintenance of cell 
identity, it is still unclear how during mitosis covalent and ATP-dependent chromatin 
modifications are transmitted after DNA replication. Indeed, a simple way for daughter cells to 
restore the transcriptional profile of mother cells is to directly ‘sense’ the transcriptome of their 
mother cells. 
In order to unveil the molecular nature of somatic cell epigenetic memory, we used classic 
Position Effect Variegation assays to check if non functional alleles of the white gene could 
modify the eye color variegation caused by an heterochromatin inversion of the white gene 
called white-mottled 4 (wm4h). Our data show that several white alleles suppress the variegation 
of the wm4h line. Unexpectedly, the presence of white alleles causes an increase in the white 
gene transcript as well as an opening in the chromatin structure at the wm4h locus. Remarkably, 
this effect is inheritable, a phenomenon highly reminiscent of RNA mediated paramutation. 
The changes in the levels of expression of the wmh4 gene, induced in trans by several white 
alleles, indicate that the presence of a non functional gene that does not produce a coding 
transcript but potentially only ncRNA, could influence in trans the expression of a functional 
copy of the same gene silenced by heterochromatin. Our data indirectly indicates that cells can 
'sense' the presence of non coding RNA’s inherited from their mother cells and can use them to 
epigenetically reset their transcriptional program after DNA replication. 
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CDH1 epigenetic regulation: a role for UHRF1 modulation via promoter associated non-
coding RNAs? 
C. Pistore1, E. Magnani1, A. Garzia1, F. Babbio1, G. Carbone2, C. Catapano2, I.M. Bonapace1 
1Dept of Theoretical and Applied Sciences, Univ. of Insubria, Busto Arsizio (VA), Italy 
2Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland 
Epigenetic silencing of tumour suppressor genes is an important step during tumorigenesis. This 
process involves several mechanisms including DNA methylation and histone modifications. 
UHRF1 is a multi-domain protein able to recognize both DNA and histone silencing marks, 
coupling the preservation of histone-modification through the cell cycle with maintenance of 
DNA methylation. Recently it has been demonstrated that UHRF1 is over-expressed in several 
tumours and that its over-expression correlates to tumour progression.In the last years several 
evidences showed that also non-coding RNAs (ncRNAs) play a pivotal role in epigenetic 
regulation. In particular, it has been demonstrated that ncRNAs mediate the epigenetic silencing 
of many genes, in a process termed transcription gene silencing. 
In this work we demonstrated that, in prostate cancer cell lines, UHRF1 mediates epigenetic 
silencing of many tumour suppressor genes such as, E-cadherin gene CDH1, through the 
binding with its promoter and the recruitment of the histone-methyltransferase Suv39H1. Our 
data demonstrated that the aggressive androgen-independent cells (PC3) express high levels of 
UHRF1, while the low tumorigenic androgen-dependent cells (LNCaP) show low levels of 
UHRF1, according to the low and high level of CDH1, respectively. Then, we demonstrated that 
PC3 and LNCaP express two promoter associated ncRNAs, sense and antisense directed, 
transcribed from CDH1 promoter. In particular, LNCaP showed both sense and anti-sense 
ncRNAs, whereas PC3 cells expressed only sense ncRNA. In PC3 the knockdown, through 
targeted siRNAs, of UHRF1 impaired Suv39H1 binding to the CDH1 promoter and induced 
CDH1 and antisense-directed promoter associated ncRNA re-expression. Supported by these 
data we can hypothesize that in prostate cancer cells not only UHRF1 but also promoter-
associated ncRNAs are involved in CDH1 transcriptional silencing and they could be part of the 
same regulatory network. 
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A long non-coding RNA links copy number variation to a Polycomb/Trithorax epigenetic 
switch in FSHD muscular dystrophy 
D. Gabellini 
Dulbecco Telethon Institute at San Raffaele Scientific Institute, Division of Regenerative medicine, Stem cells, and 
Gene therapy, Milan, Italy 
Repetitive sequences account for more than 50% of the human genome. While once thought of 
primarily as “junk”, recent studies indicate that repeated elements play central roles in regulating 
gene expression at multiple levels. Interestingly, in mammals the bulk of several epigenetic 
marks is located in genomic repeats and it has been suggested that they could provide binding 
platforms for chromatin regulators. Hence, elucidating the role of these elements in setting up 
functional chromatin states in complex genomes is of paramount importance. 
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant disease associated 
to reduction in the copy number of the D4Z4 repeat mapping to 4q35. By an unknown 
mechanism, D4Z4 deletion causes an epigenetic switch leading to de-repression of 4q35 genes. 
We have that the Polycomb group of epigenetic repressors targets D4Z4 in healthy subjects and 
that D4Z4 deletion is associated with reduced Polycomb silencing in FSHD patients. We have 
identified DBE-T, a chromatin-associated non-coding RNA produced selectively in FSHD 
patients that coordinates de-repression of 4q35 genes. DBE-T recruits the Trithorax group 
protein Ash1L to the FSHD locus, driving histone H3 lysine 36 dimethylation, chromatin 
remodeling and 4q35 gene transcription. 
Our study provides insights into the biological function of repetitive sequences in regulating 
gene expression and shows how mutations of such elements can influence the progression of a 
human genetic disease. 
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Molecular basis of hHP1β/nucleosome interaction in dependence of histone 3 methylation 
F. Munari1, S. Soeroes2,6, H. M. Zenn3, A. Schomburg2,6, N. Kost2, S. Schröder2,4, R. Klingberg5,  
N. Rezaei-Ghaleh1, A. Stützer2, K. A. Gelato2, P. J. Walla4, S. Becker1, D. Schwarzer5,  
B. Zimmermann3, W. Fischle2, M. Zweckstetter1 
1Dept for NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany 
2Laboratory of Chromatin Biochemistry, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany 
3Biaffin GmbH & Co KG, Kassel, Germany 
4Biomolecular Spectroscopy and Single-Molecule Detection, Max Planck Institute for Biophysical Chemistry, 
Göttingen, Germany 
5Protein Chemistry, Leibniz-Institut für molekulare Pharmakologie, Berlin, Germany 
6Current Address: Oxford Nanopore Technologies LTD, Oxford, United Kingdom (SS), Proteros biostructures 
GmbH, Martinsried, Germany (AS) 
A large variety of post-translational histone modifications regulate chromatin structure and 
function. Methylation of lysine 9 within the H3 N-terminus governs the packaging of DNA into 
heterochromatin, a highly condensed and gene-silent form of chromatin. The recognition of 
trimethylated Lys9 in histone3 (H3K9me3) by heterochromatin proteins 1 (HP1) constitutes a 
key step in the establishment and maintenance of heterochromatin1. 
Previous works on component systems using isolated histone peptides and/or individual 
domains of the protein2,3,4, as well as using HP1 proteins of different species or isoforms5,6,7, have 
determined various domains and interaction interfaces of HP1 binding to chromatin. The large 
variability of findings precludes from deducing a coherent picture of HP1/nucleosome binding. 
In particular structural and biophysical insights have been missing in this picture so far. 
By using a combination of NMR, biophysical and biochemical experiments on a fully defined 
recombinant system we have investigated the molecular basis of hHP1β binding to methylated 
(H3K9me3) and unmodified nucleosomes. Our results provide the first detailed analysis of the 
dynamic, structural and thermodynamic parameters of hHP1β binding to nucleosome in 
dependence of K9 methylation on histone 3. 
1. Grewal SI, Elgin SC. Nature 447: 399-406; 2007 
2. Nielsen PR, et al. Nature 416: 103-107; 2002 
3. Nielsen AL, et al. Mol Cell 7: 729-739; 2001 
4. Lavigne M, et al. PLoS Genet 5: e1000769; 2009 
5. Meehan RR, et al. Embo J 22: 3164-3174; 2003 
6. Zhao T, et al. J Biol Chem 275: 28332-28338; 2000 
7. Canzio D, et al. Mol Cell 41: 67-81; 2011 
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Gene co-regulation and co-localization in human chromosome 19: a knowledge-based 
computational approach 
M. Di Stefano1, A. Rosa1, V. Belcastro2, D. di Bernardo3, C. Micheletti1 
1International School for Advanced Studies (SISSA), Trieste, Italy 
2Philip Morris International R&D, Philip Morris Products S.A., Neuchatel, Switzerland 
3Telethon Institute of Genetics and Medicine (TIGEM), Napoli, Italy 
Clarifying the link between transcriptional regulation and 3D chromatin organization is one of 
the major open issues in molecular biology. Here, we tackle “in-silico” a specific aspect of this 
complex relationship, namely that the spatial proximity of chromatin fibers should enhance co-
regulation of the corresponding hosted genes (``gene kissing'' hypothesis, G. Cavalli, Curr. Opin. 
Genet. Dev. 2007). 
Specifically, we have extended the computational polymer model for interphase chromosomes 
recently proposed by Rosa and Everaers (Plos Comput. Biol., 2008), by including putative 
propensities for gene-gene contacts based on co-expression data. The gene-gene contacts were 
promoted through a steered molecular dynamics protocol on a model chromatin fiber. The 
resulting "in silico" structural organization of the fiber shows folding motifs which should be 
detected by current experimental techniques. Our model helps in formulating novel hypotheses 
on the structure-function relationship of the chromatin. 
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Wnt signalling and the reprogramming of cell fate to pluripotency 
M.P. Cosma 
Centre for Genomic Regulation (CRG), Barcelona, Spain 
Spontaneous cell fusion between two cells of different lineages can originate new hybrid cells 
that have different features from the original parent cells. If one of the fusing parent cells is 
highly plastic, such as a stem cell, and the other is a somatic cell, their fusion can be followed by 
reprogramming events that generate new hybrid pluripotent cells. However, whether cell-
fusion-mediated reprogramming can occur in vivo in higher vertebrates, and what are the 
molecular mechanisms and genes that drive the reprogramming, remain to be defined. We have 
shown that activation of the Wnt/β-catenin signalling pathway enhances reprogramming of 
somatic cells after their fusion with embryonic stem cells. We are currently dissecting out the 
gene networks and studying the mechanisms of in-vivo somatic-cell reprogramming, to 
determine whether reprogrammed hybrids have the potential to differentiate and regenerate 
tissues. 
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The Hippo transducer TAZ confers cancer stem cell traits on breast cancer cells 
downstream of epithelial-to-mesenchymal transition and the deregulation of the cell 
polarity determinant Scribble 
M. Cordenonsi, F. Zanconato, L. Azzolin, S. Piccolo 
Dept of Biomedical Sciences, Univ. of Padua, Padova, Italy 
Cancer Stem Cells (CSCs) are proposed to drive tumor initiation, heterogeneity and progression. 
Yet, our understanding of the cellular and molecular mechanisms that underlie CSC properties 
is limited. We present evidences indicating that TAZ, a transducer of the Hippo pathway, is a 
determinant of key biological traits of breast CSCs. TAZ is required to sustain self-renewal and 
tumor initiation capacities in cellular models of breast cancer progression. TAZ protein levels 
are stabilized in prospective CSCs, and gain-of-TAZ in non-CSCs induces them to adopt CSCs-
like behaviors. We found that gene-signatures denoting TAZ activity are associated with 
molecular imprints of "stemness" in breast cancer patients' datasets. In agreement with the view 
that an increase in CSCs drives tumor progression in breast cancer, the proportion of TAZ 
positive cells is much more abundant in poorly-differentiated tumors than in well differentiated 
ones. Consistently, raising TAZ levels promotes the transition of experimentally induced tumors 
toward a less-differentiated status. At the molecular level, TAZ promotes self-renewal of CSC 
downstream of Epithelial-to-Mesenchymal Transition (EMT). This is caused by deregulation of 
the cell polarity determinant Scribble, which forms an endogenous complex with TAZ in 
nontransformed and tumoral mammary epithelial cells. Remarkably, loss-of-Scribble - or 
induction of EMT - disrupts the association of TAZ with the core Hippo kinases MST and 
LATS, allowing TAZ to escape phosphorylation by LATS and association to beta-TrCP 
ubiquitin ligase complex. This study thus links the CSCs concept to the Hippo pathway in breast 
cancer, and reveals a mechanistic basis of the control of Hippo kinases by cell polarity. 
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Epigenetic regulation of L1 repetitive elements plays a role in normal myogenesis and is 
altered in Duchenne muscular dystrophy 
B. Bodega1, F. Della Valle1, V. Saccone2,3, S. Consalvi2,3, J. Martone4, V. Cazzella4, C. Mozzetta2, 
M. Mora5, P. Carninci6, I. Bozzoni4, P.L. Puri2,3, V. Orlando1 
1Dulbecco Telethon Institute (DTI) at IRCSS Fondazione Santa Lucia, Epigenetics and Genome reprogramming, 
Rome, Italy 
2Dulbecco Telethon Institute (DTI), IRCCS Fondazione Santa Lucia, Rome, Italy 
3Sanford-Burnham Institute for Medical Research, La Jolla, USA 
4Dept of Biology and Biotechnology "Charles Darwin", Sapienza Univ. of Rome, Italy 
5Division of Neuromuscular Diseases and Neuroimmunology, Istituto Nazionale Neurologico 'C. Besta', Milano, 
Italy 
6RIKEN Yokohama Institute, Omics Science Center, Yokohama, Kanagawa, Japan 
The regulation and impact of Repetitive Elements in human genome function and disease is 
largely unknown. Duchenne muscular Dystrophy is one of the most debilitating myopathies in 
humans and no effective therapies are available for this disease. Emerging findings suggest that 
lack of dystrophin, part of the dystrophin-associated protein complex (DAPC) at the 
sarcolemma, affects not only the structure of muscle fibers, but has a consistent impact on global 
genome expression regulation (i.e. protein coding genes and miRNAs), acting on the nNOS-
HDAC2 pathway 2,3,4. Here we report that the same pathway modulates somatic LINE-1 (L1) 
expression and copy number variation (CNV) during skeletal myogenesis, concomitantly with 
L1 promoter hyper-acetylation and MyoD1 binding. Small molecule inhibition of CNV reduced 
differentiation ability of normal muscle cells suggesting a role for L1 mobilization in normal 
myogenesis. We detected HDAC2 aberrant recruitment on L1 promoter, together with lower L1 
expression and no CNV in DMD muscle cells. Notably, amelioration of the dystrophic features 
using HDAC inhibitors (TSA) or exon-skipping dystrophin rescue restore L1 expression and 
CNV either in the mdx mouse model of DMD and in human DMD muscle cells. These results 
demonstrate that epigenetic regulation of L1 sequences occurs in muscle cell progenitors and 
may be a requirement for myogenesis in mammals. Moreover, we unravel a direct link between 
absence of Dystrophin and defective HDAC2 regulated L1 retrotrasposition in DMD patients 
and identify major human non coding sequences as potential new players in muscular dystrophy 
manifestation. These data suggest the relevance of studying non coding genome activity to fully 
understand human diseases. 
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MyoD regulates p57kip2 expression by interacting with a distant cis-element and 
modifying a higher-order chromatin structure 
C. Battistelli, A. Busanello, M. Carbone, C. Mostocotto, R. Maione 
Istituto Pasteur-Fondazione Cenci Bolognetti, Dept Cellular Biotechnologies and Haematology, Sapienza Univ. of 
Rome, Italy 
The bHLH transcription factor MyoD, the prototypical master regulator of differentiation, 
directs a complex program of gene expression during skeletal myogenesis. The up-regulation of 
the cdk inhibitor p57kip2 plays a critical role in coordinating differentiation and growth arrest 
during muscle development as well as in other tissues. p57kip2 displays a highly specific 
expression pattern and is subject to a complex epigenetic control driving the imprinting of the 
paternal allele. However, the regulatory mechanisms governing its expression during 
development are still poorly understood. We have identified an unexpected mechanism by 
which MyoD regulates p57kip2 transcription in differentiating muscle cells. We show that the 
induction of p57kip2 requires MyoD binding to a long-distance element located within the 
imprinting control region KvDMR1 and the consequent release of a chromatin loop involving 
p57kip2 promoter. We also show that differentiation-dependent regulation of p57kip2, while 
involving a region implicated in the imprinting process, is distinct and hierarchically 
subordinated to the imprinting control. These findings highlight a novel mechanism, involving 
the modification of higher order chromatin structures, by which MyoD regulates gene 
expression. Our results also suggest that chromatin folding mediated by KvDMR1 could account 
for the highly restricted expression of p57kip2 during development and, possibly, for its aberrant 
silencing in some pathologies. 
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Experience-dependent expression of miR132 regulates ocular dominance plasticity 
P. Tognini1,2, E. Putignano1,2, A. Coatti1,2 , D. Silingardi1, R. Mazziotti1, D. Napoli1, T. Pizzorusso1,3 
1Institute of Neuroscience CNR, Pisa, Italy 
2Scuola Normale Superiore, Pisa, Italy 
3Dipartimento di Psicologia, Univ. di Firenze, Firenze, Italy 
Brain development is characterized by temporal windows of enhanced experience-dependent 
plasticity called critical periods. Ocular dominance (OD) plasticity induced by monocular 
deprivation during the critical period is a classical model of developmental plasticity. Visual 
activation of signalling pathways converging on CREB and on histone post-translational 
modifications regulate visual cortical plasticity. Little is known about the plasticity genes 
controlled by these mechanisms. We investigated the role of miR132, a CREB induced 
microRNA controlling spine formation, in visual cortical plasticity. We found that visual 
experience dynamically regulated primary and mature miR132 expression and induced 
methylation and phosphoacetylation of histones on a CRE locus important for miR132 
transcription in the visual cortex. Monocular deprivation reduced primary and mature miR132 
expression in the cortex contralateral to the deprived eye. Counteracting miR132 reduction with 
infusion of chemically modified miR132 mimic oligonucleotides completely blocked OD 
plasticity. Furthermore, three days of monocular deprivation in miR212/132 KO mice didn’t 
induce OD shift during critical period. Thus, developmental cortical plasticity requires 
experience-dependent regulation of miR132 expression. 
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The chromatin organization of an eukaryotic genome: sequence specific + 
statistical=combinatorial 
D. Corona1,V. Di Benedetto2, R. Giancarlo2, F. Utro3 
1Dulbecco Telethon Institute c/o Università di Palermo, Dipartimento STEMBIO – Sezione Biologia Cellulare, 
Palermo, Italy 
2Univ. di Palermo, Dipartimento di Matematica ed Informatica, Palermo, Italy 
2Univ. di Palermo, Dipartimento di Matematica ed Informatica, Palermo, Italy 
3Computational Genomics Group, IBM T.J. Watson Research Center, Yorktown Heights, USA 
Nucleosome organization in eukaryotic genomes has a deep impact on gene function. Although 
progress has been recently made in the identification of various concurring factors influencing 
nucleosome positioning, it is still unclear whether nucleosome positions are sequence dictated 
or determined by a random process. It has been postulated for a long time that, in the proximity 
of TSS, a ‘barrier’ determines the position of the +1 nucleosome and then geometric constraints 
alter the random positioning process determining nucleosomal phasing. Such a pattern fades out 
as one moves away from the barrier to become again a random positioning process. Although 
this statistical model is widely accepted, the molecular nature of the ‘barrier’ is still unknown. 
Moreover, we are far from the identification of a set of sequence rules able: to account for the 
genome-wide nucleosome organization; to explain the nature of the barriers on which the 
statistical mechanism hinges; to allow for a smooth transition from sequence-dictated to 
statistical positioning and back. Here we show that sequence complexity, quantified via various 
methods, can be the rule able to at least partially account for all of the  above. In particular, we 
have conducted our analyses on four high resolution nucleosomal maps of the model eukaryotes 
S.cerevisiae, C. elegans and D.melanogaster, and found that nucleosome depleted regions can be 
well distinguished from nucleosome enriched regions by sequence complexity measures. In 
particular, the depleted regions are less complex than the enriched ones. Moreover, around TSS, 
complexity measures alone are in striking agreement with in vivo nucleosome occupancy, in 
particular precisely indicating the positions of the +1 and -1 nucleosomes. Those findings 
indicate that the intrinsic richness of subsequences within sequences plays a role in nucleosomal 
formation in genomes, and that sequence complexity constitutes the molecular nature of 
nucleosome ‘barrier’.  
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The increase in complexity of the RNA landscape: new functions of non coding RNAs 
M. Cesana, D. Cacchiareli, V. Cazzella, M. Morlando, J. Martone, C. Pinnarò, I. Legnini,  
I. Bozzoni 
Dept of Biology and Biotechnology, Sapienza Univ., Rome 
It is becoming largely accepted that the non-coding portion of the genome, and not the coding 
counterpart, is likely to account for the greater complexity of higher eukaryotes. Many new 
functions have been assigned to non-coding RNAs both in the nucleus and in the cytoplasm. 
Among the small non-coding RNAs a relevant role is certainly played by microRNAs. In 
animals, they are implicated in an increasingly wide variety of biological processes and their 
expression appears to be tissue-specific and highly regulated according to the cell's 
developmental lineage and stage. While thousands of mammalian genes are potentially targeted 
by miRNAs, the functions of miRNAs in the context of gene networks controlling cell 
differentiation is a relevant issue awaiting a complete definition. However, it is becoming clear 
that these molecules occupy very high hierarchical positions in the cascade of regulatory events 
controlling cell specification. 
Likewise what happened for the very well known small non-coding RNAs, long non-coding 
RNAs (lncRNAs) are now attracting much interest. 
Even if a large fraction of lncRNAs has not been yet characterized, several general features have 
been identified indicating that they should play physiological relevant functions and may 
represent a major regulatory component of the eukaryotic genome (Mattick, 2011, FEBS Letters 
585: 1600). The discovery of biologically meaningful lncRNAs provides an additional layer of 
gene expression regulation at the level of chromatin modification, transcription and post-
transcriptional control. 
Among the many different functions, one resulted particularly attractive: coding and non-coding 
RNAs were described to regulate one another through their ability to compete for microRNA 
binding; these molecules have been termed competing endogenous RNA (ceRNA). ceRNAs can 
sequester microRNAs, thereby protecting their target mRNAs from repression (Salmena et al., 
2011, Cell, 146, 353-358). 
Data will be presented on the relevant role of both small and long non-coding RNAs in proper 
cell differentiation programmes (Cesana et al., 2011, Cell, 147: 358-369). 
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A new paradigm for HIV-1 chemotherapy: targeting the host cell viral cofactor DDX3 
A. Garbelli1, S. Beermann2, G. Di Cicco1, U. Dietrich2, G. Maga1 
1Institute of Molecular Genetics, National Research Council, Pavia, Italy 
2Georg-Speyer-Haus Institute of Biomedical Research, Frankfurt, Germany 
DEAD-box proteins are enzymes endowed with nucleic acid-dependent ATPase and unwinding 
activities. The human DEAD-box protein DDX3 has been shown to play important roles in 
tumor proliferation and viral infections. For this reason, DDX3 seems a prime target for viral 
manipulation, however only limited information is available on its biochemical properties. 
We have started to characterize the biochemical properties of DDX3, as a necessary step for the 
subsequent development of specific inhibitors of its enzymatic activities. 
In particular we investigated the functional role of a unique insertion between motifs I and Ia of 
DDX3 and provide evidence for its distinct functions in mediating the interaction with nucleic 
acids and in coupling RNA and DNA binding to ATP hydrolysis. We also show that human 
DDX3 can act as a DNA helicase with a 5'->3' directionality and provide evidence for an 
important role of the DDX3 specific module for this activity. 
Next, given the role of DDX3 in the HIV-1 life cycle, we aimed to develop small-molecules 
inhibitors of DDX3 as potential anti-HIV agents. In fact, compounds currently used for the 
treatment of HIV-1 infections are targeted to viral proteins. However, cellular cofactors 
represent attractive new targets for HIV-1 chemotherapy, since they should be less prone to 
accumulate drug resistance mutations. 
We have identified the first non-nucleosidic compounds suppressing HIV-1 replication by 
targeting the ATPase activity of human DDX3. A hit optimization protocol was applied to these 
compounds which led to design and synthesis of second generation derivatives with better 
inhibitory activity toward the cellular DDX3 enzyme and HIV-1 replication. These results 
provide a proof-of-principle for the feasibility of blocking HIV-1 infection by rendering the host 
cell environment less favorable for the virus. 
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PcG-mediated higher order chromatin structures modulate replication programs at the 
Drosophila BX-C 
F. Lo Sardo1*, C. Lanzuolo2*, F. Comoglio4, M. de Bardi3 , R. Paro4,5 , V. Orlando1 
1Dulbecco Telethon Institute at IRCCS Santa Lucia FoundationEpigenetics and Genome Reprogramming, Rome, 
Italy 
2CNR Institute of Cellular Biology and Neurobiology, IRCCS Santa Lucia Foundation, Rome, Italy 
3Neuroimmunology Unit, Santa Lucia Foundation at the European Brain Research Institute, Rome, Italy 
4Dept of Biosystems Science and Engineering, Swiss Federal Institute of Technology Zürich, Basel, Switzerland 
5Faculty of Science, Univ. of Basel,Basel, Switzerland 
Polycomb group of proteins (PcG) are conserved transcriptional regulators required for the 
maintenance of repressed transcriptional states, acting directly on specific chromatin regions via 
post-translational histone modifications and higher order structures formation. During S-phase, 
in addition to DNA, PcG mediated epigenetic signatures need to be duplicated to preserve the 
cell identity, requiring a tight coordination between PcG proteins and replication programs. 
However, to date the mutual regulation between replication and PcG-functions is still unknown. 
To address this issue we used Drosophila embryonic cell lines, performing genome-wide 
bioinformatic analyses followed by functional experiments on the well characterized BX-C locus. 
We found that transcription per se is not the sole determinant of cellular replication timing, 
whereas higher order structures can dictate the timing of replication. In particular, using 
available datasets, we show that, at a genome-wide scale, PRC1 and PRC2 complexes differently 
correlate with replication timing of their targets. On the other hand, at the repressed BX-C, 
where both complexes are bound, loss of function experiments followed by replication timing 
analysis revealed a synergistic role for PcG proteins in the maintenance of replication programs 
through the mediation of BX-C higher order structures, as measured by Chromosome 
Conformation Capture. In line with this observation, replication timing analysis performed on 
two Drosophila cell lines presenting different BX-C conformations, revealed a cell type specific 
replication program that mirrors the characteristic BX-C higher order structures. Our work 
suggests that PcG complexes, by modulating higher order chromatin structure at their target 
sites, contribute to the definition and the maintenance of genomic structural domains where 
genes that are co-regulated replicate at the same time. 
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Dissecting the tumor suppression activity of the bromodomain containing protein BRD7 
A. Comel1,2, F. Mantovani1,2, G. Del Sal1,2 
1Dept Life Sciences, Trieste Univ., Trieste, Italy 
2Laboratorio Nazionale CIB, Area Science Park, Padriciano, Trieste, Italy 
The p53 family proteins, namely p53, p63 and p73, are key inhibitors of tumor development and 
progression. Among p53’s major anticancer responses are oncogene-induced senescence and 
DNA damage-induced apoptosis; moreover, p53 also promotes DNA repair, inhibits 
angiogenesis, alters energy metabolism and regulates stemness. All these activities are mainly 
achieved through p53’s transcriptional activity that is finely modulated by several p53-
interacting partners in response to both physiological inputs and to oncogenic stress. 
Our research group has recently demonstrated that the bromodomain-containing protein BRD7, 
a component of chromatin remodeling complexes, acts as a transcriptional cofactor of wild-type 
p53 in promoting the expression of genes that regulate growth arrest and DNA repair. BRD7 
appears to be essential for protecting normal human fibroblasts from oncogene-induced 
transformation and we found low BRD7 expression specifically in a subgroup of human breast 
tumors harboring wild-type, but not mutant, p53. Notably, BRD7 was shown to interact with the 
tumor suppressor protein BRCA1 and to co-regulate a subset of target genes, among which the 
DNA repair factor Rad51 and the estrogen receptor α. Moreover, it has recently emerged that 
BRD7 regulates the expression of the Bmi-1 oncogene, required for self-renewal properties of 
stem cells. All the above findings point towards a more general role of BRD7 in modulating the 
transcription of genes involved in cancer development and progression. In particular, gene 
expression analysis of human fibroblasts upon HRASV12 induction and BRD7 depletion 
suggests a possible involvement of BRD7 in regulating processes such as cell motility, energy 
metabolism and secretion of important cell-signaling mediators. Therefore, we took advantage 
of these observations to investigate the role of BRD7 loss in specific steps of breast cancer 
progression, with particular relevance to acquisition of metastatic and stem-cell properties. 
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A high-throughput imaging approach to study Aurora-A inhibition in human cells 
I.A. Asteriti, E. Di Cesare, P. Lavia, G. Guarguaglini 
CNR Institute of Molecular Biology and Pathology (IBPM), c/o Sapienza Univ. di Roma,Roma, Italy 
The faithful segregation of the replicated genomes in mitosis requires an intricate regulatory 
programme for the cyclic  build-up of a functional mitotic spindle.  Misassembly or misfunction 
of the mitotic spindle can yield imbalanced chromosome segregation, aneuploidy and hence cell 
transformation. Many of the underlying processes are driven by phosphorylation events 
orchestated by  mitotic kinases, some of which are abnormally expressed in cancer cells and are 
regarded as attractive targets in cancer therapy. Aurora-A, a mitotic kinase regulating several 
aspects of spindle assembly, is overexpressed in many tumor types. Using siRNA-based post-
trascriptional silencing, we have recently characterised a number of molecular processes 
regulated by Aurora-A, including the organisation of spindle poles and the balance of forces 
within the spindle. We have now developed in vivo imaging methods to record the fate of living 
cells after treatment with MLN8237, a highly specific inhibitor of Aurora-A currently under 
clinical trial. Our results depict unforeseen, potentially dangerous effects of Aurora-A 
inhibition-based therapeutic protocols which could not have been revealed using conventional 
cell molecular methods. This work highlights the power of in vivo imaging protocols to 1) 
unravel the biological effects of Aurora-A inhibition, 2) depict the origin of defects at the single 
cell level which may originate a genetically unstable somatic cell clone and 3) identify conditions 
that may influence the outcome of Aurora-A targeted therapy. 
This work was developed in part as a proof-of-concept study  in the EuroBioImaging consortium 
(EMBL, Heidelberg) and was supported in part by a SIBBM grant award to  LAA. 
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Molecular control of satellite cell lineage progression and muscle regeneration through a 
novel Cripto -dependent mechanism 
G. Minchiotti 
Stem Cell Fate Laboratory, Institute of Genetics and Biophysics “A. Buzzati-Traverso”, CNR, Naples 
Skeletal muscle regeneration mainly depends upon satellite cells, a population of resident muscle 
stem cells. Despite extensive studies, the molecular mechanisms underlying satellite cell 
mobilization and skeletal muscle regeneration still remain undefined. We have identified the 
EGF-CFC protein Cripto as a new, unpredicted player of skeletal muscle regeneration. Cripto is 
a multifunctional protein acting as a modulator of the TGFß family signalling pathway. Despite 
the well-described role of Cripto in early embryogenesis and in the multiple signalling networks 
that orchestrate Embryonic Stem Cell (ESC) differentiation, its function in adult life remains 
elusive. We provide unprecedented evidence that Cripto is re-expressed in the early phases of 
skeletal muscle regeneration, in regenerating myofibers. Conditional inactivation of cripto in 
adult satellite cells compromises skeletal muscle regeneration, whereas gain of function of 
Cripto accelerates regeneration leading to muscle hypertrophy. Moreover, we show that Cripto 
modulates myogenic cell determination and promotes proliferation of satellite cells by 
antagonizing the TGFβ ligand Myostatin. Our data provide new insights in the molecular and 
cellular basis of Cripto activity in skeletal muscle regeneration and satellite cell mobilization, 
raising novel implications for stem cell biology and regenerative medicine. 
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Reprogramming cellular identity for in vitro modeling and replacement therapy of 
Parkinson's disease 
M. Caiazzo1, M.T. Dell'Anno1, I. Theka1, S. Curreri2, D. Leo2, A. Dityatev2, R. Gainetdinov2, 
V. Broccoli1 
1San Raffaele Scientific Institute, Milan, Italy 
2Italian Institute of Technology (IIT), Genoa, Italy 
Having access to human neurons for regenerative therapies and understanding diseases has been 
prohibited for long time. However, genetic technologies of cell reprogramming have wide 
opened this possibility by in vitro differentiation of fibroblast-derived iPS cells. However, a new 
method of cell reprogramming has become available which convert fibroblasts directly into 
functional neurons without passing through a pluripotent stem cell stage (iPSCs). This 
technology has some relevant advantages since it is very fast and efficient and can be employed 
with human adult fibroblasts. Recently, we found a minimal set of three transcription factors 
(Mash1, Nurr1 and Lmx1a) able to efficiently convert mouse and human fibroblasts into 
functional dopaminergic neuronal (iDAN) cells. Molecular and transcriptome studies showed 
iDAN cells to recapitulate gene expression of their brain homolog neurons to large extent while 
lacking expression of other monoaminergic and cathecolaminergic neuronal subtype markers. 
Transgene expression is necessary for only 6 days to achieve a stable cell conversion sustained by 
activation of the endogenous genes of the three reprogramming factors. Strikingly, iDAN cells 
showed spontaneous electrical activity organized in regular spikes consistent with the 
pacemaker activity featured by brain DA neurons and produce and release dopamine. 
Furthermore, iDAN cells express D2 autoreceptors and their activity is regulated by the D2/3R 
agonist quinperole. The three factors were able to elicit DA neuronal conversion in prenatal or 
adult fibroblasts from healthy donors and Parkinson’s disease patients. Mouse iDAN cells 
integrated in orthotopic brain side after transplantation in the forebrain structures and matured 
into functional neurons. Importantly, when transplanted in rats unilaterally lesioned with 6-
OHDA, iDAN cells were able to rescue drug-induced locomotor impairment over long time. We 
have recently improved human iDAN cell reprogramming conditions in order to establish an 
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UHRF1-dependent miRNAs modulate Dnmt3a expression in prostate transformed cells 
F. Babbio1, V. DelVescovo2, F. LaMastra1, M. Grasso2, I. Castiglioni1, M. Mandruzzato1, 
C. Pistore1, E. Magnani1, M.A. Denti2, I.M. Bonapace1 
1Dept Theoretical and Appplied Sciences, Univ. of Insubria, Busto Arsizio VA, Italy 
2CIBIO Center, Univ. of Trento, Trento, Italy 
MicroRNAs are a class of small (21-22 nucleotides) non-coding RNAs that negatively control 
gene expression. It is being increasingly recognized that microRNAs constitute a class of gene 
modulators that play crucial functions in fundamental cellular processes and a growing body of 
evidence indicated their deregulated expression in human tumours, proposing microRNAs as 
novel oncogenes or tumour suppressors. 
We have recently demonstrated that UHRF1 protein is an epigenetic “crosstalker” involved in 
prostate cancer progression and its depletion determines reactivation of numerous tumour-
suppressor genes. In this study, we investigate whether this UHRF1 role could include changes 
in microRNAs levels in prostate transformed cells (PC-3). 
Interestingly, microRNAs expression profile of siRNA-UHRF1 PC-3 cells showed both increased 
and decreased miRNAs levels. 
Using different predictive softwares to identify putative microRNAs targets, Dnmt3a appears to 
be a putative target of two miRNAs, which are overexpressed in siRNA-UHRF1 PC3 cells. 
Dnmt3a is a DNA de novo methyltransferase highly expressed in various malignancies, 
including prostate tumours. The overexpression of the two miRNAs was confirmed by RT-PCR 
in siRNA-UHRF1 compared to siRNA-CTRL PC-3 cells. We also observed a Dnmt3a protein 
reduction in UHRF1 depleted PC-3 cells. The direct binding of the two miRNAs to the 3’UTR of 
Dnmt3a and its potential inhibitory effect was functionally validated using a reporter luciferase 
system. We then studied the effect of the overexpression of the two miRNAs in PC-3 cells 
finding a decrease of Dnmt3a mRNA and protein. 
Next goal in our project is to identify and study miRNA promoters, and evaluate a direct or 
indirect role of UHRF1 in miRNAs transcription. 
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Comprehensive analyses of noncoding RNAs in Polycomb-mediated myogenic differentiation 
M. Baniol1, B. Bodega1, P. Carninci2, T. Ravasi3, V. Orlando1  
1Dulbecco Telethon Institute at IRCCS Santa Lucia, Epigenetics and Genome Reprogramming lab, Rome, Italy 
2Omics Science Center, RIKEN Yokohama Institute, Yokohama, Japan 
3KAUST, Thuwal, Saudi Arabia 
Epigenetic mechanisms play a major part in myogenesis. Polycomb group proteins (PcG) are 
epigenetic regulators able to maintain the repressive state of specific set of genes involved in cell 
fate determination by controlling chromatin structure. It is now established that they play a key 
role in the maintenance of the skeletal muscle progenitors identity and that their dynamic 
regulation is crucial for terminal muscle differentiation.  Over the past few years, studies have 
also unraveled the ability of non-coding RNAs to directly interact with PcG proteins and to be 
necessary for gene silencing. Still, the real extent of non-coding RNAs contribution to Polycomb 
recruitment and function remains to be determined. Our project aims at identifying and 
characterizing non-coding RNAs involved in PcG-mediated gene regulation, and their specific 
role in the myogenic differentiation program.Using techniques relying on high-throughput 
technologies, such as CAGE, ChIP-seq and RIP-seq, we are generating a set of databases where 
dynamic changes in transcription profile, Polycomb binding sites and Polycomb-associated 
RNAs are analyzed genome-wide in C2C12 myoblasts and derived myotubes. The crosstalk 
between these different databases will eventually lead us to an integrated view of the molecular 
machineries that control the specific recruitment of PcG complexes on their chromatin target 
sites. Such a deeper understanding of both PcG and ncRNA functions in myogenesis regulation 
could be of great relevance to determine the molecular basis of muscle diseases in humans. 
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Using chromosome conformation capture as an antibody-independent sensitive melanoma 
biomarker 
E. Bastonini, L. Sanchez Del Campo Ferrer, C.R. Goding 
Ludwig Institute for Cancer Research, University of Oxford, Headington, Oxford, United Kingdom 
Despite some decades of research almost half of patients diagnosed with cancer die of the 
disease. The failure of approaches to cancer therapy reflects an underlying problem: cancer cell 
population heterogeneity. Without having a marker set that distinguishes between cancer sub-
populations it is not possible to know which population is being targeted in any therapy. 
Although antibodies against differentiation-associated markers are used, in most cancers no 
markers for invasive stem-like populations have been identified. Since chromatin structure may 
be related to or independent from gene expression, chromatin signatures represent an 
alternative to antibody markers that are strictly dependent on expression. Chromosome 
Conformation Capture (3C) can detect early changes in epigenetic regulatory signatures at loci 
implicated in cancer. Malignant melanoma is a cancer known for its resistance to most 
therapies. The microphthalmia-associated transcription factor (MITF) is not only the master 
regulator determining the identity of the melanocyte lineage, but it also has a critical role in 
melanoma by regulating survival, differentiation, proliferation and invasiveness. In melanoma 
biopsies, MITF marks a distinct sub-population of melanoma cells providing an illustration of 
melanoma tumor heterogeneity. Hence, depending on its expression level, MITF can have pro- 
or anti-proliferative effects. We used 3C assays to understand whether chromatin organization 
at the MITF gene is controlled by genomic interactions in three dimensional space. Using 
human cells and blood samples from melanoma patients, we identified multiple 3C signatures 
associated with MITF that may represent both expression dependent and independent 
chromatin conformations. In this context the role of the p66 protein of the NURD complex is 
significant for MITF chromatin loops. Thus, we propose that a distinct chromatin architecture 
coordinated by p66/NURD complex accompanies transcriptional activation of MITF. 
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The PDZ-ligand and SRC-homology type 3 domains of epidemic avian influenza virus NS1 
protein modulte human SRC kinase activity during viral infection 
L. Bavagnoli1, W.G. Dundon2, A. Garbelli1, B. Zecchin2, A. Milani2, G. Parakkal1, F. Baldanti3,  
S. Paolucci3, R. Volmer4, Y. Tu5, C. Wu5, I. Capua2, G. Maga1 
1Institute of Molecular Genetics National Research Council, Pavia, Italy 
2World Organization for Animal Health, Food and Agriculture Organization and National Reference Laboratory for 
Newcastle Disease and Avian Influenza, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy 
3Molecular Virology Unit, Virology and Microbiology, Fondazione Istituto Ricovero e Cura a Carattere Scientifico 
Policlinico S. Matteo, Pavia, Italy 
4Universite´ de Toulouse, Institut National Polytechnique, Ecole Nationale de Veterinaire, Unite` Mixte de 
Recherche 1225, Interactions Hotes-Agents Pathoge`nes, Toulouse, France 
5Dept of Pathology, Univ. of Pittsburgh, Pittsburgh, Pennsylvania, United States of America 
The Non-structural 1 (NS1) protein of avian influenza (AI) viruses is important for 
pathogenicity. NS1 is not a structural component of the virion, but it is expressed at very high 
levels in infected cells. NS1 inhibits host immune response limiting both interferon (IFN) 
production and the antiviral effects of IFN-induced proteins. The last six aminoacids (225-230) 
of NS1, in strains of avian origin, constitute a PDZ-binding domain (PL), which allows 
interaction with a wide range of cellular proteins. We have identified in the last 12 amino acids 
of the C-terminal region of AI H7N1 NS1 a previously unreported rearrangement constituted by 
two consecutive PL motifs (TPL, Tandem PDZ-Ligand). Using a protein array, we have 
identified the cellular protein RIL (Reversion Induced-LIM) as the primary ligand protein of 
NS1. It is known that RIL interacts with the active form of tyrosine kinase Src, playing a leading 
role in its regulation. The avian NS1 proteins also contain two Src-homology type 3 binding 
domain (SHB), thus we tested its ability to physically and functionally interact with Src, both in 
the presence or absence of RIL, through enzymatic and pull down assays. The results show that 
NS1 is able to physically interact with Src, and to stimulate its enzymatic activity. In infected 
cells, the levels of phosphorylated (active) Src correlate with the ability of NS1 to bind RIL 
through its TPL domain, suggesting an interplay among these three protrins. However, the exact 
role of Src activation in the avian influenza virus life cycle is still unknown. Bioinfomratic 
analysis of the human proteome, identified several potential cellular ligands for avian NS1. 
Due to its potential binding to multiple partners, NS1 can interfere with different cellular 
pathways. Our findings are aimed at defining a therapeutic strategy that can reduced the 
emergence of viral resistance towards antiviral drugs, based on the selective targeting of host 
factors required for viral replication. 
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Epigenetic regulation of HBV cccDNA 
L. Belloni1,2,3, L. Allweiss4, F. Guerrieri1,2,3, N. Pediconi1,2,3, T. Volz4, T. Pollicino5, J. Petersen6,  
G. Raimondo5, M. Dandri4, M. Levrero1,2,3 
1EAL Inserm U785, Sapienza University of Rome, Rome, Italy 
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4Dept of Internal Medicine, Univ. Medical Hospital Hamburg-Eppendorf, Hamburg, Germany 
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The HBV cccDNA is the nuclear replicative intermediate of HBV and is the template for all viral 
messenger RNAs. It is organized into minichromosomes in the nucleus of infected cells by 
histone and non-histone proteins and its function is regulated, similarly to cellular chromatin, by 
the activity of nuclear transcription factors, transcriptional coactivators and corepressors and 
chromatin modifying enzymes. We developed a chromatin immunoprecipitation (ChIP)-based 
quantitative technique that allows to define the enzymatic activities that bind to and regulate 
transcription/replication from the cccDNA minichromosome. We previously showed that HBV 
replication is regulated, both in a cell replication system and in the liver of HBV chronically 
infected patients, by the acetylation status of cccDNA-bound H3/H4 histones. 
Interferon-alpha (IFNα) is an effective treatment for hepatatis B virus (HBV) infection. We 
observe that IFNα exerted an inhibitory effect on HBV replication. Inhibition of replication was 
paralleled by a very strong decrease in pgRNA transcription without observing significant 
changes in the levels of cccDNA. Using a cccDNA specific chromatin immunoprecipitation 
assay we found that, in response to IFNα, cccDNA-bound histones are hypoacetylated and 
transcriptional co-repressors HDAC1, hSIRT1 and Ezh2 are actively recruited onto the cccDNA. 
Moreover, we also show that both STAT1 and STAT2 transcription factors are recruited onto 
the cccDNA and their binding is reduced after IFNα treatment. An ISRE mutant HBV doesn’t 
have STAT2 bound to the cccDNA, transcribes less viral RNA, cannot be repressed by IFNα and 
fails to recruit HDAC1 in response to IFNα. Altogether our results indicate that IFNα can affect 
the transcriptional activity of the cccDNA epigenetically and provide a molecular mechanism for 
IFNα repression of HBV transcription. 
Palermo | 24-26 May 2012 
 
 — 40 — 
P6 
Characterisation of a novel long non coding RNA potentially involved in neuronal 
differentiation  
V. Bevilacqua1, U. Gioia1, I. Bozzoni1,2,3, E. Caffarelli2,3 
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Recent genome-wide analyses have shown that mammalian genomes are pervasively transcribed 
and encode many thousands of non coding RNAs (ncRNAs) that differ for size, biogenesis and 
function. Notably, a large number of these transcripts exert regulatory functions, contributing to 
the complexity of higher eukaryotes. Long non coding RNAs (lncRNAs), greater than 200 
nucleotides in length, are one of the most abundant class of ncRNAs transcribed in a 
developmentally regulated and cell-specific manner. Despite their abundance, only a small 
fraction of lncRNAs has been associated to biological functions or disease processes. An ideal 
model system for studying the relevance of such molecules is the nervous system, whose 
development is a highly regulated process orchestrated by several different regulatory 
mechanisms acting at both the transcriptional and post-transcriptional level. In line with such 
complexity, it has been shown that a half of all lncRNAs is expressed in the central nervous 
system (Quereshi et al., 2010). 
Starting from our studies aimed at unveiling microRNAs (miRNAs), a class of short ncRNAs 
with regulatory functions, involved in neuronal differentiation we identified a lncRNA in which 
miR-125b-1 coding region is embedded (linc125b-1). As the miRNA, linc125b-1 is upregulated 
during in vitro differentiation of human neuroblastoma cells, suggesting that the expression of 
the two non coding RNAs is co-regulated during the differentiation process. Notably, linc125b-
1, that has a predominant cytoplasmic localization, displays several putative binding sites for 
miRNAs known to counteract cellular differentiation. Functional studies are in progress to verify 
its potential role as competing endogenous RNA (ceRNA), which may be directly implicated in 
the choice of neuronal differentiation programs by sequestering specific miRNAs that inhibit 
such process (Poliseno et al., 2010; Cesana et al., 2011). 
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Italian strains of Babesia bovis: first description of surface antigens and molecular markers 
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S.E. Wilkowsky3, M. Florin Christensen3 
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Babesiosis is a tick-born disease mainly transmitted by the tick Rhipicephalus spp. Among 
bovine parasites, Babesia bovis is one of the most relevant pathogens, causing in its hosts a 
severe anaemia, high fever and, sometimes, the death. Many efforts are directed to the study of 
B. bovis surface antigens as vaccine candidates, as well as to the finding of new molecular 
markers to track the strains provenience. 
Two Italian strains of B. bovis were analysed to amplify genes codifying for the Merozoite 
Surface Antigen 2c (MSA-2c) and for the Apical Membrane Antigen-1 (AMA-1), two proteins 
deeply studied thanks to their possibility to be included in a subunit vaccine. The two sequences 
were amplified in the Italian strains, cloned and sequenced and the data obtained were 
compared with those available in GenBank. Both MSA-2c and AMA-1 showed at aminoacidic 
level a very high percentage of identity each other (93.0 % for MSA-2c and 99.4% for AMA-1) 
and with the sequences annotated in GenBank (an average of 93.8% for MSA-2c and of 97.2% for 
AMA-1). Furthermore, six B-cell epitopes were identified in the MSA-2c aminoacidic sequences 
by bioinformatics. Out of these, two were entirely conserved among Italian and geographically 
distant strains. 
Genes recently identified suitable for molecular markers, Desmoyokin and 85KDa, were also 
amplified and sequenced. The analysis allowed defining the repeats pattern of Italian strains. 
Interestingly, it was noted a conservation in the consensus pattern, but Italian strains showed a 
pattern never found in foreign strains. 
The obtained results constitute the first information related to Italian strains of Babesia bovis 
and reinforce the hypothesis to use MSA-2c and AMA-1 proteins as vaccine candidates and 
Desmoyokin and 85KDa genes as molecular markers. 
The research was supported by the Italian Ministry of Health (IZSSI 11/10). Thanks to Rosa 
Filippi and Franco Ferraro for their technical support. 
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Eukaryotic cells store their genetic information into chromatin, in which genomic DNA is 
associated with histone and non histone proteins, forming an highly dynamic structure involved 
in the control of numerous biological processes, including transcription, cell division, 
differentiation and DNA repair. Chromatin plasticity is the result of the combined action of 
ATP-dependent chromatin remodelling activities and histone modifying enzymes, which 
modulate the epigenetic marks of eukaryote genome. In contrast to the well-characterized 
histone modifications, such as acetylation and methylation, the role of histone ubiquitination in 
chromatin remodelling remains the least understood despite a long history of its discovery. We 
found that effete, the gene encoding for the putative ubiquitin E2 conjugating enzyme UbcD1, 
genetically interacts with the ATP-dependent chromatin remodeler enconding gene ISWI, 
suggesting a potential role of UbcD1 in chromatin modulation. The analysis of Drosophila effete 
knock-down polytene chromosomes reveals not only chromatin condensation defects, highly 
reminiscent of those caused by loss of ISWI, but also a dramatic enhancement of those defects 
when the knock-down in induced in ISWI genetic background. Moreover effete loss of function 
causes a clear decrease of chromosomal mono-ubiquitylated H2B level. Interestingly we found 
that overexpression of osa, a recently identified E3 ubiquitin ligase specific for H2B, partially 
suppresses both chromosomes condensation defects and lethality induced by effete knock-down, 
suggesting that mono-ubiquitylated H2B level could be directly linked to chromosomes 
condensation levels. Moreover, loss of UbcD1 induces global loss of the linker histone H1, 
suggesting the intriguing possibility that UbcD1 and its ubiquitylating activity could be among 
the factors regulating higher order chromatin structure.  
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TRIM8: a new key modulator of the p53 pathway 
M.F. Caratozzolo1, F. Mastropasqua2, I. Aiello1, T. Lopardo3, F. Marzano1, A. Valletti4,  
A.M. D’Erchia2, G. Pesole2,4, E. Sbisà1, L. Guerrini3, A. Tullo1 
1Istituto Tecnologie Biomediche ITB, CNR-Bari, Bari, Italy 
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3Dipartimento di Science Biomolecolari e Biotecnologie, Univ. di Milano, Milano, Italy 
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p53 regulation occurs through a vast number of mechanisms and the inactivation of its pathway 
is a common feature of human cancer. 
We found that human TRIM8, a member of the TRIM family, is a new modulator of the p53-
mediated tumour suppression mechanism. Under genotoxic stress, p53 induced the expression 
of TRIM8, which in turn stabilized p53 and promoted the degradation of MDM2, the principal 
regulator of p53 stability. Co-immunoprecipitation experiments showed that TRIM8 physically 
interacted with p53, impairing its interaction with MDM2 (Caratozzolo MF et al., 2012). 
TA and ΔN isoforms of the p53 family members display a fine and very complex interplay 
between them. Therefore, we investigated the effect of TRIM8 on the oncogenic ΔNp63α, the 
main p63 isoform involved in cancer development. We found that TRIM8 overexpression 
induced degradation of ΔNp63α in a dose dependent manner, while its silencing resulted in a 
pronounced accumulation of endogenous ΔNp63α accompanied by a decrease of p53 levels in 
parallel with an increase in cell proliferation. 
Interestingly, only the TRIM8 mutant protein lacking the RING domain was unable to suppress 
cell proliferation, to promote stabilization of p53 and degradation of both MDM2 and ΔNp63α. 
Thus, we tested whether TRIM8-RING domain alone was able to enhance p53 activity. Indeed, 
overexpression of the TRIM8-RING domain induced cell cycle arrest in a p53-dependent 
manner. 
Altogether, our results reveal a new regulatory pathway controlling p53 and ΔNp63α activities 
and suggest TRIM8 as a novel therapeutic target to simultaneously enhance p53 oncosuppressor 
and impair ΔNp63α oncogenic activities. 
Acknowledgements: This work was supported by Fondazione Cassa di Risparmio di Puglia (prot. 
277/11) to A.Tullo. 
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Identification of GABA receptor genes and evidence of GABA signaling during embryogenesis 
of the sea urchin 
S. Casamirra, G. Spinelli, V. Cavalieri 
Dept Molecular and Biomolecular Sciences and Technologies (STEMBIO), Univ. of Palermo, Italy 
Gamma-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the 
mammalian central nervous system and acts via ionotropic (GABAA-Rs) and metabotropic 
(GABAB-Rs) receptors. GABAA-Rs are Cl- selective hetero-pentameric channels assembled by 
combinations of 19 distinct gene products. Instead, GABAB-Rs are bi-subunit G-protein coupled 
receptors linked to K+ or Ca2+ channels. Dysfunctions of GABA-signaling (GS) cause psychotic 
disorders and correlate with epigenetic alterations, such as over-expression of DNA methyl 
transferase-1 which in turn imposes iper-methylation of GABA-regulated genes. The sea urchin 
embryo, which presents a rudimentary nervous system, offers a big opportunity to study the GS 
and its potential epigenetic implications in a simple eukaryote model. To this purpose, we 
performed a comprehensive in silico analysis of the sea urchin genome and identified a 450 Kb 
long cluster containing two genes encoding for the GABAB-R subunits, and two genes 
respectively encoding for a α/γ/ε-type and a β/ρ/δ/τ/π-type GABA
B
A-R subunit. From an 
evolutionary perspective, this result revealed a unique genomic organization of these genes in 
sea urchin. Next, to preliminarily evaluate the role of GS during development, Paracentrotus 
lividus embryos were cultured in the presence of GABA at concentrations ranging from 0.01 to 
1.0 mM. Compared to controls, treated embryos showed aberrations in axial patterning, with a 
dose-dependent effect. In particular, at 48 hours post-fertilization control embryos were normal 
bilateral symmetric plutei whereas GABA-treated embryos displayed a radial organization with 
supranumerary spicules. Washout experiments allowed to determine that the period of 
sensitivity is restricted from the blastula to the gastrula stage. Altogether, these results suggest 
that dysregulation of GS affects the polarization of the ectoderm. Although preliminary, this 
study provide the first evidence of GS activity during development of echinoderms. 
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Relationship between autophagy and apoptosis in Paracentrotus lividus embryos cadmium 
exposed 
R. Chiarelli, M. Agnello, G. Morici, M.C. Roccheri 
Dept STEMBIO (Biologia Cellulare) Univ. of Palermo, Italy 
Cadmium is a strong toxicant for living organism since it does not have biological roles and can 
cause several cellular damages comprising genotoxicity, oxidative stress, and other biochemical 
dysfunctions. Marine invertebrate embryos represent a suitable model system where to 
investigate the effects of many stressors on development and cell viability. Here we investigated 
the toxic effect of cadmium on sea urchin Paracentrotus lividus embryos focusing our attention 
on metal-inducead autophagy and the possible temporal and functional relationship with 
apoptosis. 
Using several techniques to detect autophagy (neutral red, acridine orange and LC3-detection) 
we demonstrated that Cd-exposed P. lividus embryos adopt this process as an additional 
stratagem to safeguard the developmental program. In particular we observed that embryos 
treated at subletal Cd concentration activate a massive autophagic response after 18h, which 
decreases between 21 and 24h, in the opposite of apoptotic process. 
In order to investigate a possible temporal relationship between autophagy and apoptosis, we 
tested apoptotic signals by TUNEL and immunofluorescence in situ assays of cleaved caspase-3. 
Quantitative analysis has shown that embryos activate a massive apoptosis after 24h of Cd-
exposure. Therefore a functional relationship between autophagy and apoptosis was estimated 
evaluating apoptotic signals in Cd-exposed embryos, upon treatment with the autophagic 
inhibitor 3-methyladenine. We found that the inhibition of autophagy produced a 
contemporaneous reduction of apoptotic signals, suggesting that the two phenomena are 
functionally related. In effect using methylpyruvate, a cell-permeable substrate for ATP 
production, apoptotic signals were substantially restored. 
These data could be explained considering that autophagy could energetically contribute to 
apoptotic execution through its catabolic role. 
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LSD2: A new flavin-containing histone demethylase 
G. Ciossani, A. Karytinos, M. Foglizzo, C. Binda, A. Mattevi 
Dept of Biology and Biotechnology "L. Spallanzani", Univ. of Pavia 
For long time the methylation of histone lysines was considered an irreversible epigenetic 
modification, but the discovery of the first Lysine Specific Demethylase (LSD1), showed the 
dynamic regulation of this mark. 
LSD1, in complex with the corepressor CoREST and recruited by different multiprotein 
complexes, is involved in many biological processes like cell differentiation and development. 
In addition to the LSD1 gene (aof2), mammalian genomes contain a second gene (aof1) coding 
for a protein, named LSD2, that is 33% identical to LSD1. Despite this similarity, LSD2 differs 
from LSD1 in that it contains a N-terminal CW-type zinc finger and lacks the Tower domain, 
the domain responsible for the interaction with CoREST. Our studies demonstrated that also 
LSD2 is a flavin-dependent lysine-specific histone demethylase, biochemically very similar to 
LSD1. Differently from LSD1, this protein does not interact with CoREST and the class 1 
Histone Deacetylases (HDACs) 1 and 2. Taken together, these data indicate that LSD2 belongs 
to macromolecular complexes distinct from those of LSD1, suggesting a completely different 
biological role. A little is known about the biology of LSD2: In mice, it is mainly expressed in 
intestinal glands and during late oogenesis, when its activity is fundamental for the correct 
establishment of DNA methylation patterns. 
The aim of my PhD project is the structural and biochemical characterization of LSD2. So far, 
the efforts to crystallize the single domains or the entire LSD2 protein, from both human and 
mouse, gave no results. 
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Role of ISWI chromatin remodeler in epigenetic reprogramming occuring in regeneration 
and transdetermination 
G. D’Angelo1,2, D.F.V Corona1,2 
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Epigenetic modifications of chromatin structure sustain cell fate determination over multiple 
mitotic divisions throughout development, setting the epigenetic cell memory, thus the cell 
identity. Several evidences demonstrated that in all metazoan, chromatin modifications are 
reversible also in terminally differentiated cells. During regeneration, a well evolutionarily 
conserved phenomenon , yet determined cell do not only proliferate but extensively reprogram 
their epigenetic memory to regenerate missing parts of injured tissue. Moreover, during 
regeneration, the plasticity of chromatin structure allows cells to switch cell identity thus to 
trans-determine their cell fate. 
Accumulating evidences suggest a crucial role of chromatin remodelers in epigenetic 
reprogramming occurring in regeneration and transdetermination, still molecular mechanisms 
underlying these processes are poorly understood. D. melanogaster larval imaginal discs, the 
precursor of fly appendages, provide a unique system to investigate about the potential of cell to 
regenerate and to transdetermine. 
Our aim is to investigate the role of the ATPase-dependent chromatin remodeler ISWI and its 
previously identified genetic modifiers in epigenetic reprogramming events occurring during 
regeneration and transdetermination. 
We are employing the heat inducible “flp-out” method to generate fly stocks carrying clones of 
imaginal disc cells with high transdetermining or high regenerating potential. We will compare 
the transdetermination and the regeneration rates of this induced clones to ISWI modifiers yet 
identified in our lab, in order to identify genes enhancing or suppressing epigenetic 
reprogramming. 
Our study will hopefully provide crucial insights into the roles that ATP−dependent chromatin 
remodeling reactions may play in transdetermination and into the ability to control tissue 
regeneration. 
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A role for the lysine-specific demethylase 1 (LSD1) in hepatic stem cell fate determination 
C. Cicchini1, V. De Nonno1, L. Amicone1, S. Valente2, M. Tardugno2, A. Mai2, M. Tripodi1 
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A number of hepatic stem cell lines named RLSCs (from Resident Liver Stem Cells) were 
previously stabilized and characterized in our lab (Conigliaro et al., 2008). These cells 
spontaneously differentiate into periportal hepatocytes that, in turn, are able to switch into 
perivenular hepatocytes (Colletti et al., 2009). RLSCs show a metastable molecular phenotype 
typical of embryonic and adult stem cells and characterized by co-expression of epithelial and 
mesenchymal markers as well as of a variety of chromatin remodeling genes. This highly 
dynamic cell state, thought to be the major determinant of stem cell fate, may be considered as 
the result of continue oscillations between Epithelial-to-Mesenchymal Transition (EMT) and 
the reverse Mesenchymal-to-Epithelial Transition (MET). 
Taking into account the recently reported role for the lysine-specific demethylase1 (LSD1) in 
triggering EMT, we hypothesized that a bulk changes in histone modifications might underlie 
the EMT/MET dynamics in the metastable molecular phenotype of the hepatic stem cells, 
influencing their differentiation potential. 
By using of specific chemical inhibitors, we unveiled a role for LSD1 in influencing the RLSC 
plasticity. 
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FAIRE and 3C analysis of chromatin modifications induced by the HNF1β transcription 
factor in the albumin/alpha-foetoprotein (alb/AFP) 
M. Olivieri, G. D’Agostino, A. Ingenito, V. De Pasquale, L. De Magistris, V. De Simone 
Dept of Biochemistry and Medical Biotechnology, Univ. “Federico II”, Napoli, Italy 
AIMS OF THE PROJECT: To investigate the role of the HNF1β transcription factor in the 
commitment of epithelial cells to the hepatic fate by inducing modifications of the chromatin in 
a complex locus containing two liver-specific genes. 
SCIENTIFIC BACKGROUND: Hepatic Nuclear Factor 1 beta (HNF1β) transcription factor is 
expressed very early during development, approximately when the hepatic fate and, differently 
from its cognate HNF1α, largely before any liver-specific gene is expressed. These two factors 
bind the same DNA target sequences and their protein sequences are very similar in the DNA 
binding domain, but remarkably different in the C-terminal domain. Our working hypothesis is 
that HNF1β acts mainly as a chromatin modifier, by increasing the accessibility of HNF1α and 
other liver-specific factors to the main regulatory elements of liver-specific genes. The 
albumin/alpha-foetoprotein (alb/AFP) locus is a good candidate for chromatin modification 
analysis, since it contains several regulatory elements scattered in a 40 kb region. Moreover, the 
locus is involved into a developmentally regulated foetal/adult transcriptional switch. 
METHODOLOGY: Chromatin extracted from hepatic and non-hepatic human and mouse cell 
lines transfected with expression vectors containing the HNF1β coding region have been 
analysed by FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements) and 3C 
(Chromosome Conformation Change) techniques to reveal modifications of the accessibility 
and/or the formation of loops between distant regulatory elements. 
RESULTS: Our preliminary results indicate that transfection of HNF1β in non-hepatic cells 
increases the accessibility of albumin and AFP promoters, while HNF1α or a truncated form of 
HNF1β (deprived of the C-terminal region) do not induce any chromatin modification. 3C 
experiments in both hepatic and non-hepatic cell lines are currently in progress. 
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LINE1 copy number changes during transdifferentiation of MEF into iDA neurons 
F. Della Valle1, M. Caiazzo2, B. Bodega1, V. Broccoli 2, V.Orlando1 
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LINE1 class of repetitive elements is composed by sequences capable of active retrotrasposition 
and by elements carrying deletion in the 5' UTR or mutation inside the ORF sequence that stuck 
those one in their position. (Moutri et al.2005).Some papers in the latest years showed that 
repetitive elements can be very important for the establishment of a gene expression profiles. It 
is also recently demonstrated that full-lenght LINE1 mRNA is expressed in iPSC and an 
engineered LINE1 can retrotraspose much better in iPSC than in HDF, because reprogramming 
reinstates LINE1 trascription and creates the environment required for their reintegration in the 
genome (Wissing et al.2011). It seems reasonable to hypothesize that If L1 retrotrasposition 
activity is foundamental for a physiological gene expression pattern; it could be important to 
remobilize these repetitive sequences during transdifferentiation. This may allow the 
remodeling of the chromatin required for the switch of gene expression profile. The 
transdifferentiation of embryo fibroblast into induced dopaminergic neurons(iDA), by the 
overexpression of three neural transcription factors and using a neural colture media(Caiazzo et 
al.2011), represents a suitable model for studying the involvement of LINE1 in the cell fate 
decision. We already analized L1 copy number during myogenic differentiation and we observed 
a different copy number patient of Duchenne muscular dystrophy respect to healthy donors. For 
those reason we begin the analysis of full length L1 elements transcription and copy number 
variation during transdifferentiation process whit a specific taqman assay showed a gradual 
increase of LINE1 expression and number of copy of those elements. Taken together, those data 
may effort the idea that LINE1 can be remobilized under a specific signaling pathway when the 
cell fate is established during differentiation. Moreover remobilization of this class of repetitive 
element may be crucial to obtain a more efficient reprogramming protocol. 
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Mechanisms of altered transcriptional regulation in the pathogenesis of AEC syndrome 
G. Ferone1,2, A. SIrico1, C. Missero1,2 
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The p53 homologue p63 is a tetrameric transcription factor with a pivotal role in stratified 
epithelial development and maintenance. Heterozygous mutations in p63 cause at least five 
closely-related inherited disorders, among which Ankyloblepharon-Ectodermal dysplasia-
Clefting (AEC) syndrome is characterized by severe involvement of the skin. To elucidate the 
molecular mechanisms underlying this disorder, we previously generated a knock-in mouse 
model (p63+/L514F) carrying a clinically relevant missense mutation in the carboxyl-terminal 
region of the p63α isoform, in which AEC mutations are clustered. p63+/L514F mice are affected by 
cleft palate, skin hypoplasia and ectodermal dysplasia, thus faithfully recapitulating the 
phenotype observed in AEC syndrome. Cleft palate and skin hypoplasia are caused by 
hypoproliferation of epithelial progenitors and reduced number of epidermal stem cells 
associated with downregulation of FGF signalling and FGFR2 expression. 
Mechanistically we find that mutant p63L514F protein retains the ability to form tetramers with 
itself and the wild-type protein, however the tetramer has an impaired transactivation activity. 
In mutant cells reduced transactivation is associated with partially impaired p63 binding to DNA 
in the chromatin context and a modest impairment of tri- and di-methylation of histone H3 at 
lysine 4 at the p63 binding sites. Consistently, in the absence of the wild-type protein, p63L514F 
is severely impaired in its ability to bind DNA in the genomic context and is unable to 
transactivate its target genes. These findings indicate that mutant p63 acts in a dominant-
negative fashion affecting p63 ability to transactivate crucial targets in epidermal development. 
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Molecular characterization of the RNA binding motif protein 20: determination of nuclear 
localization signals 
A. Filippello, P. Lorenzi, C. Morandi, M.G. Romanelli 
Dept of Life and Reproduction Sciences, Section of Biology and Genetics, Verona, Italy 
RNA splicing is a tightly regulated process that involves the spliceosome and additional RNA 
binding proteins that can repress or activate splice sites selection. Recent studies have indicated 
that mutations in RBM20, a gene encoding a novel ribonucleic acid – binding protein, are 
associated to human dilated cardiomyopathy (DCM). RBM20 regulates alternative splicing of 
expressed genes that have a key role in cardiac function, including ion homeostasis, sarcomere 
biology, and signal transduction. The functional motifs of the RBM20 protein, have been poorly 
investigated. The focus of this study is to characterize the protein domains that contribute to the 
nuclear function of RBM20. Predictive in silico analysis of the translated RBM20 gene identifies 
an RNA recognition motif (RRM motif), a serine /arginine (RS) domain and Zn2+ finger domains. 
We have produced GFP-RBM20 fusion proteins in order to map the functional domains of the 
protein that contribute to subcellular distribution. We have produced truncated mutants of the 
RBM20 proteins and analyzed separately in immunofluorescence assays in transfected cells. We 
identified a region necessary and sufficient to nuclear localization of RBM20 protein that maps 
between the RRM and the RS domain. Actually we are producing RBM20 mutant proteins in 
order to characterize the nuclear localization signal (NLS). RBM20 is the first RNA binding 
protein associated to DCM. Further structural and functional characterization of RBM20 may 
contribute to understand the molecular pathogenesis of familiar DCM. 
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Functional complementation of yeast sir2Δ mutation by the human orthologous gene SIRT1 
D. Gaglio, E. Cesarini, A. D'alfonso, G. Camilloni 
Dept of Biology and Biotechnology "Charles Darwin", Univ. of Rome SAPIENZA, Rome, Italy 
Sirtuins (SIRTs 1-7), or class III histone deacetylases (HDACs), are deacetylases/ADP 
ribosyltransferases that target a wide range of cellular proteins in the nucleus, cytoplasm, and 
mitochondria for post-translational modification by deacetylation (SIRT1, -2, -3 and -5) or ADP 
ribosylation (SIRT4 and -6). The orthologs of Sirtuins in lower organisms play a critical role in 
regulating lifespan, aging and metabolic diseases. The mammalian Sirtuins SIRT1-SIRT7 are 
implicated in a variety of cellular functions ranging from gene silencing, over the control of cell 
cycle and apoptosis, to energy homeostasis. On a whole-body level, Sirtuins display a wide range 
of activities in the cell, which suggests that they may constitute therapeutic targets to contrast 
metabolic, neurodegenerative (Parkinson and Alzheimer), and proliferative diseases such as 
cancer. 
Specifically, this project is about the molecular cloning of the human sirtuin member SIRT1 in 
Saccharomyces cerevisiae. We cloned this enzyme into an engineered yeast plasmid with a 
galactose inducible promoter and we used it for heterologous expression in S. cerevisiae mutants 
for the ortholog SIR2. To verify total or partial complementation, after having established that 
SIRT1 have no toxic effect on yeast, we studied their behaviour by analyzing different molecular 
phenotypes such as: i) the transcriptional repression in rDNA, HM loci and telomeres; ii) 
histone deacetylation (H4K16) and iii) the production of extrachromosomical rDNA circles 
(ERCs). The aim of this work is to determine whether human gene complementation occurs in 
Saccharomyces cerevisiae in order to use yeast as a model organism to conduct molecular 
studies on diseases where these enzyme is involved, e.g., Parkinson’s, Alzheimer’s, prostate 
cancer and diabetes. A more specific use of this complemented yeast strain is the screening of 
activator and inhibitor molecules of Sirtuins for therapeutical approach. 
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ADAR2 editing activity inhibits glioblastoma growth through the modulation of the 
CDC14B/Skp2/p21/p27 axis 
F. Galeano1, S. Tomaselli1, L. Cifaldi1, L. Massimi2, F. Locatelli1,3, A. Gallo1 
1Oncohaematology Dept, IRCCS Ospedale Pediatrico “Bambino Gesù”, Rome, Italy 
2Policlinico Gemelli, Pediatric Neurosurgery Dept, Rome, Italy 
3Univ. di Pavia, Pavia, Italy 
Grade IV astrocytoma or glioblastoma multiforme (GBM) is one of the most aggressive and 
lethal tumors affecting humans. ADAR2-mediated A-to-I RNA editing, an essential post-
transcriptional modification event in brain, is impaired in GBMs and astrocytoma cell lines. 
However, the role played by ADAR2 editing in astrocytomas remains to be defined. 
Here, we show that ADAR2 editing rescue in astrocytomas prevents tumor growth in vivo and 
modulates an important cell-cycle pathway involving the Skp2/p21/p27 proteins, often altered in 
glioblastoma. We demonstrate that ADAR2 deaminase activity is essential to inhibit tumor 
growth. Indeed, we identify the phosphatase CDC14B, which acts upstream of the Skp2/p21/p27 
pathway, as a novel and critical ADAR2-target gene involved in glioblastoma growth. 
Specifically, ADAR2-mediated editing on CDC14B pre-mRNA increases its expression with a 
consequent reduction of the Skp2 target protein, as shown both in vitro and in vivo. We found 
that, compared to normal brain, both CDC14B editing and expression are progressively 
impaired in astrocytomas from grade I to grade IV, being very low in GBMs. 
These findings 1) demonstrate that post-transcriptional A-to-I RNA editing might be crucial for 
glioblastoma pathogenesis, 2) identify ADAR2 editing enzyme as a novel candidate tumor-
suppressor gene and 3) provide proof of principle that ADAR2 or its substrates may represent a 
suitable target(s) for possible novel, more effective and less toxic approaches to the treatment of 
GBMs. 
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Genome-wide analysis of the repertoire of TRIM genes in sea urchins 
R. Guarcello, G. Spinelli, V. Cavalieri 
Dept Molecular and Biomolecular Sciences and Technologies (STEMBIO), Univ. of  Palermo, Italy 
The eukaryotic TRIM (TRIpartite Motif) super-family represents one of the largest classes of 
putative E3 ubiquitin ligases involved in several processes, including epigenetic control of 
development and disease. In the post-genomic era, new approaches allow genome-wide studies 
of gene family. In particular, we performed a comprehensive analysis of the TRIM repertoire in 
selected sea urchin species. By combining iterations of ab initio predictions and pairwise 
comparative methods, we first retrieved the full complement of TRIM genes in 
Strongylocentrotus purpuratus, whose full genome sequence was available. Interestingly, such a 
DNA sequence set includes not previously classified, echinoderm-specific, TRIM genes as well 
as multiple copies of known ones. We also retrieved a landscape of cDNA sequences from staged 
EST libraries, indicating that most of these genes are actively transcribed during development. 
Phylogenetic analysis of the deduced proteins, using set of TRIMs from various species, revealed 
a degree of genetic variation between species. Worth of mention, we predicted the occurrence of 
transposition events involving some of these genes, according with the documented rapid 
evolution of this family. Next, we adopted heuristic algorithms and post-processing steps to 
investigate the evolutionarily distant Paracentrotus lividus, Allocentrotus fragilis and Lytechinus 
variegatus genomes, whose sequencing projects are actually in progress. We assembled partial 
pools of TRIM genes and specifically associated them to EST-derived cDNA sequences. Such a 
collection of data should provide a framework for unravel gene regulatory networks involving 
TRIM genes from an evolutionary perspective. Indeed, in the Pl species, we have previously 
isolated and functionally characterized the cDNA sequence encoding the first echinoderm 
TRIM factor, Strim1. Here, we identified five strim1 genes, all sharing a intronless organization, 
and roughly located their cis-regulatory apparatus. 
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A functional loop involving the viral protein HBx and miR224 regulates HBV transcription 
and replication 
F. Guerrieri, C. Scisciani, L. Belloni, A. Sbardellati, D. D’Andrea, A. Tramontano, M. Levrero, N. 
Pediconi 
Dept of Internal Medicine, DMISM, Sapienza Univ., Rome, Italy, Rome, Italy 
miR224 is frequently up-regulated in HBV and HCV-related HCCs, whereas its levels are low in 
acute HBV hepatitis. miR224 expression in the liver has been shown to be induced by the NFkB-
dependent inflammatory pathways. We sought to characterize the transcriptional regulation of 
miR224 in HBV replicating cells, the role of HBx and miR224 effects on HBV replication. The 
HBV replicative intermediate cccDNA is the template for transcription of all viral mRNAs, and 
it accumulates in the nucleus of infected cells as a stable minichromosome. We have recently 
shown that HBV transcription and replication are regulated by epigenetic changes of cccDNA-
bound histones mediated by the recruitment of both cellular chromatin modifying enzymes and 
the HBx viral regulatory protein. HBx has been also shown to bind the promoter regions of 
cellular genes. In a genome wide search of HBx cellular targets by ChIP-Seq we found that HBx 
binds in vivo to the miR224 regulatory region. HBx binding is accompanied by the co-
recruitment of p65/NFkB, the recruitment of the DNMT3a and reduced H4 histone acetylation. 
Accordingly, miR224 levels are reduced in HBV replicating cells and exogenously expressed HBx 
repressed the miR224(pr) in luciferase reporter assays. pre-miR224 overexpression reduces HBV 
pgRNA levels and leads to a 50% inhibition of HBV replication. In silico analysis revealed the 
presence of several miR224 seed sequences on the HBV genome that were conserved across 
HBV genotypes. The functional analysis of miR-224 HBV seed sequences shows that multiple 
pgRNA seeds are targeted by mir224. Our results identify a functional regulatory loop between 
HBx, miR224 and HBV replication where HBx repression of miR224 expression relieves the 
negative effects of miR224 on HBV replication. These results are compatible with the recent 
observation that miR224 are low in acute HBV infection as compared to chronic infection and 
HCC and with the low HBV replication observed in HCC tissues. 
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MicroRNA regulation by mutant p53 oncoprotein 
F. Garibaldi, G. Bossi, A. Sacchi, G. Piaggio, A. Gurtner 
Experimental Oncology Dept, Istituto Regina Elena, Rome, Italy 
Deregulated miRNA expression has been documented in diverse cancers. Although miRNAs can 
function as both tumour suppressors and oncogenes in tumour development, a widespread 
downregulation of miRNAs is commonly observed in human cancers and promotes cellular 
transformation and tumorigenesis. Still, the mechanisms through which miRNAs are regulated 
in cancer remain unclear. Wtp53 is a key tumor suppressor mutated in approximately 50% of 
human cancers. Mutp53 proteins can acquire GOF activities favoring tumor induction, 
maintenance, spreading. miRNAs can be regulated by wtp53 at transcriptional level but data 
about mutp53 dependent miRNA expression are not available yet. wtp53 interaction with the 
Drosha processing complex facilitates the processing of pri-miRNAs to pre-miRNAs. On the 
contrary, an overexpressed mutp53 desrupted p68/Drosha interaction. Taken together, these 
data support the idea that mutp53 might exert its GOF activity being responsible for the miRNA 
downregulation present in cancer. 
In order to identify new mechanisms underlying mutp53 GOF activity associated with 
dysregulation of microRNA in cancer, we have performed a genome wide analysis of miRNA 
expression in colorectal adenocarcinoma SW480 before and after mutp53 depletion. Our 
preliminary results reveled that mutp53 depletion is associated with up-regulation of 31 mature 
miRNAs (corresponding to 41 miRNA genes) and down-regulation of only 3 miRNAs. 
Validation of genome wide miRNA expression profile by qRT-PCR analysis for mature forms 
and primary precursors (pri-miRNAs) shows that mutp53 plays a role both at transcriptional 
and posttranscriptiona level. 
All together these preliminary results suggest a main role for mutp53 in the down-regulation of 
miRNA expression in cancer cells. 
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Mesenchymal stem cells isolated from different genders and body regions show differences 
in plasticity linked to the regulation of hox genes 
D. Khan1, Y. Zhang1, S. Barman1, A. Pansky1, B. Brand-Saberi2, E. Tobiasch1 
1Dept of Natural Sciences, Bonn-Rhine-Sieg Univ. of Applied Sciences, Rheinbach, Germany 
2Dept of Anatomy and Molecular Embryology, Ruhr-Univ. Bochum, Bochum, Germany 
Degenerative diseases are the major cause of death and morbidity in the industrialized world. In 
these diseases such as in osteoporosis deterioration of tissue occurs. Stem cells are considered to 
be a promising tool for future repair approaches of the damaged tissue. 
Adipose tissue derived stem cells (ATSCs) have been isolated from various regions of the body. 
According to the literature they are mesenchymal stem cells (MSCs) and should have generally 
the potential to differentiate into cell types of different tissues such as osteoblasts, adipocytes 
and chondrocytes. Here we show that these stem cells isolated from different body regions and 
genders execute differences in plasticity. MSCs obtained from thigh showed a stronger 
differentiation towards osteogenic lineage if compared to the cells from belly. 
Hox genes are involved in the patterning of the anterior to posterior axis and in segmental 
identity. These genes play a key role in differentiation and organogenesis during embryonic 
development and are also expressed in adults. Therefore we investigated if these genes are linked 
to the discriminative differentiation potential of stem cells isolated from different genders and 
body regions. We found that HoxA3, HoxB6, HoxB8 and HoxC5 were up-regulated strongly in 
female donors during osteogenic induction. HoxB6 and HoxC5 were up-regulated during 
adipogenic differentiation in all tested donors. 
We conclude that Hox genes might be good candidate to trigger stem cell differentiation, 
especially towards the osteogenic lineage. 
Correspondence: edda.tobiasch@h-brs.de 
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Constitutive inhibition of muscle differentiation by senescence-activated DNA damage 
signaling 
L. Latella1,3, M. Simonatto1, F. Marullo1, PL. Puri1,2 
1Istituto Dulbecco Telethon, IRCCS Santa Lucia Fondation and European Brain Research Institute, Rome, Italy 
2The Burnham Institute for Medical Research, San Diego, USA 
3Institute of Translational Pharmacology, National Research Council of Italy, Rome, Italy 
Upon exposure to genotoxic stress, skeletal muscle progenitors coordinate DNA repair and the 
activation of the differentiation program, by the DNA damage-activated “differentiation 
checkpoint” (DC), which prevents the transcription of differentiation genes during the DNA 
repair. We have shown that in myoblasts, DNA damage-activated cAbl phosphorylates MyoD at 
tyrosine 30 (Y30) that transiently inhibits MyoD-dependent transcription following DNA 
damage, and is reversed possibly upon the successful repair of the lesion (1). The presence of a 
cAbl consensus site discriminates MyoD from the functional paralog Myf5 and from other 
muscle bHLH proteins in executing the DC (2). 
In this study we show that the constitutive, endogenous DNA damage signaling associated with 
cellular senescence triggers a persistent DC that constitutively inhibits the myogenic program 
induced by MyoD. Indeed, replicative senescence fibroblasts become progressively resistant to 
MyoD-mediated myogenic conversion, in coincidence with the senescence-activated DNA 
damage signaling. Conversely, abrogating the DC response by using the Y30F-MyoD 
unresponsive to cAbl phosphorylation, we show that senescent cells are again proficient to 
differentiate. 
We also observed that the ability of Y30F-MyoD to bypass the constitutive DC elicited in 
senescent cells and to convert senescent fibroblasts is coupled with the induction of the cell 
cycle from a G0 senescent state. The transition into a new round of DNA replication may serve 
to make competent tissue-specific chromatin loci for gene expression. 
These results indicate a close coordination between DNA damage-activated checkpoints, 
progression into the cell cycle and control of tissue-specific gene expression, and reveal a novel 
role of the DNA damage signaling as a key mediator of the functional antagonism between 
cellular senescence and terminal differentiation. Moreover our data underscore an emerging 
new role of MyoD in regulating DNA synthesis as a critical phase to epigenetically determine 
cellular fates. 
(1) Puri PL, et al. Nat Genet. 2002 
(2) Innocenzi A, Latella L, et al. EMBO Rep. 2011 
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Cytotoxic effects induced by JA47, a novel histone deacetylase inhibitor (HDACi), on 
MDA-MB231 breast cancer cells 
M. Librizzi1, A. Longo1, M. Agnello1, J. Amin2, J. Spencer3, C. Luparello1 
1Dipartimento STEMBIO, Univ. di Palermo, Italy 
2School of Science at Medway, Univ. of Greenwich, United Kingdom 
3Dept of Chemistry, Univ. of Sussex, United Kingdom 
It is acknowledged that epigenetic alterations are involved in the repression of tumor suppressor 
genes and the promotion of tumorigenesis in cancers; for this reason, novel compounds 
endowed with HDAC inhibitory activity are considered as an attractive anti-cancer therapeutic 
approach. Here, we describe the biological effects induced by the novel HDACi JA47, an organo-
metallic SAHA analogue [1] on viability/proliferation, cell cycle progression, 
apoptosis/autophagy induction and mitochondrial activity/ROS accumulation of a triple-
negative highly-tumorigenic breast cancer cell line, MDA-MB231, taken as an in vitro model 
system of “aggressive” breast carcinoma. Viability and growth rate were determined using an 
MTT assay, and the results obtained strongly suggest that JA47 exerted a cytotoxic effect with 
an IC50 = 8.45 μM at 72 h. Different sets of experiments performed at 24 and 48 h of exposure 
to JA47 indicate that it induced a non-apoptotic cell death, as evaluated by an annexin assay, 
characterized by the accumulation of cells in the G1 and subG0 phases of the cycle. Moreover, 
we observed a prominent reduction of acidic vesicular organelles (AVO), hallmarks of 
autophagy, in JA47-treated cells, which may be related to a deprivation of energy supply 
indispensable for tumor cell survival. In addition, we also demonstrated that JA47 affected 
mitochondrial activity, as shown by a JC-1 assay, and triggered generation of reactive oxygen 
species; noteworthy, cytotoxicity was reversed in a dose-dependent manner by co-incubation 
with the anti-oxidant butylated hydroxytoluene. We conclude that JA47 plays a potential anti-
tumoral role towards triple-negative breast carcinoma cells via autophagy down-regulation and 
oxidative injury. 
1. Spencer et al. Synthesis and biological evaluation of JAHAs: ferrocene-based class I histone 
deacetylase inhibitors. ACS Med Chem Lett 2011; 2: 358-62 
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The expression of PTHrP isoforms in differentiating human fat-derived mesenchymal stem 
cells 
A. Longo1, I. Catanzaro1, F. Caradonna1, E. Tobiasch2, C. Luparello1 
1Dept STEMBIO (Biologia Cellulare), Univ. of Palermo, Palermo, Italy 
2Dept of Natural Sciences Bonn-Rhine-Sieg, Univ. of Applied Sciences, Rheinbach, Germany 
Mesenchymal stem cells (MSCs) from fat tissue can differentiate in vitro towards osteoblasts and 
adipocytes [1], and to search for stemness/early differentiation markers, we examined the 
expression of the splicing isoforms of Parathyroid Hormone-related Peptide (PTHrP), a 
regulator of proliferation, differentiation and apoptosis. The PTHrP gene, coding for three 
protein variants of 139, 141 and 173 aa, contains two TATA promoters, P1 and P3, and a GC-
rich promoter, P2, and nine exons undergoing to alternative splicing [2]. In MSCs we found four 
mRNAs encoding for the 139 and 173 aa isoforms, whereas osteo-differentiating cells produced 
only two mRNAs encoding for the same protein isoforms, and adipo-differentiating cells only 
one mRNA encoding for the 173 aa isoform. Moreover, P2 was always silenced whereas P3 only 
in differentiated cells. Our results suggest that during differentiation, the expression of PTHrP 
isoforms becomes increasingly selective. We also examined the methylation state of P2 and P3 in 
undifferentiated and osteo-differentiating MSCs, to check the possible correlation between 
methylation and promoter silencing. In agreement with gene expression data, three CpG island 
internal sites of P2 were hyper- and partially-methylated in most DNA preparations, and CpG 
sites of P3 were methylated in differentiated cells. We conclude that PTHrP plays a role in the 
differentiation of MSCs through the selective regulation of isoforms via promoter methylation 
and that PTHrP isoform expression could be considered a putative marker of MSC 
differentiation. 
Work partly supported by Vigoni 2011 grant to E.T. and C.L. 
[1] Bunnell B. A. et al., Adipose-derived stem cells: Isolation, expansion and differentiation. 
Methods, 45 (2008) 115-120. 
[2] Southby J. et al., Alternative promoter usage and mRNA splicing pathways for parathyroid 
hormone-related protein in normal tissues and tumours. British Journal of Cancer 72 (1995) 
702-707. 
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Dissecting the role of Polycomb in protecting the identity of differentiated skeletal muscle 
cells upon environmental cues 
B. Bodega1, F. Marasca1, C. Lanzuolo2, V. Orlando1 
1Dulbecco Telethon Institute (DTI), IRCSS Fondazione Santa Lucia, Epigenetics and Genome reprogramming, 
Rome, Italy 
2CNR Institute of Neurobiology and Molecular Medicine, IRCCS Santa Lucia Foundation, Rome, Italy 
Polycomb proteins are epigenetic regulators that prevent changes in transcription and maintain 
the memory of silent genes through cell division. Despite decades of research on Polycomb 
function, little is still known about its role in terminally differentiated tissues. 
Skeletal muscle cells (C2C12) represent a paradigmatic differentiation model in which Polycomb 
complex 2 (PRC2) has been extensively studied. We already found specific dynamics of PRC2 
proteins in myoblasts and myotubes, where Ezh1 progressively substitutes the H3K27 
methyltransferase Ezh2; moreover, Ezh1 is required for myogenic differentiation and the two 
complexes (i.e. PRC2-Ezh2 and PRC2-Ezh1) differentially regulate muscle specific genes (early 
versus late differentiation genes) (Caretti 2004; Stojic 2011). It is recently reported that Ezh1 
associates with active gene regulatory regions and promotes RNA pol II elongation in 
differentiating C2C12; Ezh1 retains a weak H3K27 methyltransferase (HMT) activity, although 
highly homolog to Ezh2, and its primary function remains elusive (Mousavi 2012). 
Since H3K27 tri-methylation levels are steady in myotubes and PRC2-Ezh1 complex is correctly 
formed (Stojic 2012), we asked which could be PRC2 function in this context. 
Our working hypothesis stems from the observation that upon oxidative stress (i.e. H2O2 
treatment), global level of H3K27me3 specifically increased; ChIP data indicated increased levels 
of H3K27me3 on the regulatory regions of Ezh1 target genes, together with their reduced 
expression upon H2O2 treatment. Moreover, we detected by chromatin fractionation an 
Ezh1enrichment on chromatin fraction, suggesting its functional re-localization. RNA-seq and 
ChIP-seq (Ezh1, Suz12, H3K27 me3) analyses are ongoing in H2O2-treated myotubes. 
Hence we are addressing the possibility that PRC2-Ezh1 complex could exhibit its repressive 
function in myotubes as a signal-dependent response to protect post-mitotic cells identity from 
environmental cues.  
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A genome wide role for nuclear Dicer1 and Ago1 in transcriptional regulation in human 
cells 
K.M. Parsi*1, K. Hideya*2, N. Hornig1, A.M. Burroughs2, A. Saxena2, C. Daub2, Y. Hayashizaki2, P. 
Carninci2, V. Orlando1 
1Dulbecco Telethon Institute, Epigenetics and Genome Reprogramming, Rome, Italy 
2RIKEN Omics Science Center, RIKEN Yokohama Institute, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 
Kanagawa, Japan 
*These authors contributed equally to this work 
Small RNAs and RNA interference (RNAi) components have emerged as key effectors of 
pathways that control gene expression. The role of RNAi in the cytoplasm is well documented, 
but the role of small RNA and RNAi components in the nucleus, especially in animals, remains 
largely obscure. Here we sought to study genome wide function of RNAi factors Dicer1 and 
Ago1 proteins in human HepG2 cells. By chromatin immunoprecipitation coupled to high 
throughput sequencing (ChIP-seq) and RNA sequencing (RIP-seq) we found that human RNAi 
components Dicer1 and Ago1 strongly associate with promoters and enhancers of active gene 
loci. Furthermore, by co-immunoprecipitation experiments we found that Dicer1 interacts in 
vitro with RNA Polymerase II (Pol II) and TFIIH in an RNA dependent manner, and also it 
interacts with enhancer binding proteins, p300 and HDAC2 factors. Finally, loss of function 
experiments show that Dicer1 and Ago1 function affect the in vivo Pol II chromatin binding and 
transcriptional output. Our findings suggest that the chromatin associated RNAi components 
Dicer1 and Ago1 take part in enhancer driven transcriptional activation. 
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L-Proline controls mouse ESC metastability modulating the epigenetic signature 
S. Comes, M. Gagliardi, N. Laprano, A. Cimmino, E.J. Patriarca, M.R. Matarazzo, G. Minchiotti 
Institute of Genetics and Biophysics "A. Buzzati-Traverso", CNR, Naples, Italy 
Embryonic stem cell (ESC) metastability, i.e. their phenotypic, functional, and molecular 
heterogeneity, mainly arises from stem cells’ ability to dynamically interconvert between 
different pluripotent states in response to extracellular signals. At the extreme of this plastic 
phenotypic variation, cells display identifiable features of the two types of mouse embryo-
derived pluripotent stem cells, namely ESCs and EpiSCs (Epiblast Stem Cells), deriving from the 
inner cell mass and late epiblast or primitive ectoderm, respectively. To date, factors and 
molecular mechanisms controlling mESC metastability are far to be fully resolved. 
We have recently reported that L-Proline forces ESCs toward a novel EpiSC–like metastable 
state, namely L-Pro–induced cells (PiCs). Remarkably, unlike EpiSCs, PiCs rely on leukemia 
inhibitor factor to self-renew, colonize the embryo following blastocyst injection, and rapidly 
revert to an ESC state after L-Pro removal. 
Global gene expression analysis revealed dramatic changes in the transcriptional profiling of 
PiCs compared to ESCs. Interestingly, several histone modifier enzymes resulted deregulated, 
suggesting that L-Proline triggers epigenetic changes. In line with this hypothesis, our previous 
data showed that the ascorbic acid (VitaminC), a cofactor of the Jumonji-histone demethylases, 
antagonizes ESCs↔PiCs phenotypic transition, in a dose dependent manner. Most remarkably, 
PiCs show several phenotypic similarities with Jmjd1a and Jmjd2c knockdown ESCs, such as flat 
morphology, sensitivity to trypsin digestion as well as upregulation of specific genes. 
All together, our findings prompted us to investigate whether L-Pro treatment can induce 
changes in the epigenetic signature of ESCs. Here we report that L-Pro affects the level of both 
global and gene-specific histone lysine methylation state of ESCs, and propose a novel 
mechanism controlling ESC metastability, through L-Pro –dependent modulation of the 
epigenetic signature. 
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Transcriptional regulation of the oncosuppressor miR-342 and let-7c in myeloid cells 
S. Careccia1, A. Pelosi1, M. Levrero2, G. Piaggio1, MG. Rizzo1 
1Dept of Experimental Oncology, Laboratory of Molecular Oncogenesis, Regina Elena Cancer Institute, Rome, Italy 
2Dept of Internal Medicine, Gene expression Laboratory, Univ. “Sapienza” of Rome, Italy 
MiR-342 and let-7c are intronic microRNAs (miRNA) that can act as tumor-suppressor genes 
targeting oncogenes. Our previous studies indicate that in acute promyelocytic leukaemia (APL), 
a peculiar subtype of acute myeloid leukaemia (AML) bearing the leukaemia promoting 
PML/RARα fusion protein, miR-342 and let-7c are down-regulated in APL blasts at diagnosis, 
compared to in vitro-differentiated normal promyelocytes and their expression increase after 
ATRA treatment. However, the molecular mechanisms responsible for the modulation of their 
expression is still not characterized. Here we focus on the transcriptional regulation of these two 
miRs. We found that DNA methylation of host gene promoters does not appear to be involved 
in the regulation of these miRNAs while posttranslational status of histones have been observed 
upon ATRA treatment. Notably, we have identified for let-7c a new transcriptional start site 
(TSS) in an intron of host-gene and up-stream of the pre-miRNA. The new promoter region 
contains canonical TATA and CCAAT box elements. Interestingly, we have identified for let-7c 
a new transcriptional start site in addition to host-gene promoter. This new promoter has an 
own transcriptional activity and ATRA treatment induces, as for the host-gene promoter, an 
open chromatin configuration with an enrichment of p300 and an increase of epigenetic marks 
that correlate with a more active transcriptional state. Interestingly, we also show that the 
intragenic promoter drives transcription of let-7c depending upon the tumor hystotype. Of note, 
we also provide evidence that the intragenic promoter drives transcription of let-7c depending 
upon the tumor hystotype. These results support the model that ATRA-induced up-regulation 
of miR-342 and let-7c in APL cells may be mediated by epigenetic events. 
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Identification of A-to-I RNA editing sites in human brain and spinal cord by RNA-Seq 
technology 
E. Picardi1,2, A. Gallo3, S. Raho3, F. Galeano3, S. Tomaselli3, G. Pesole1,2 
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3Laboratorio di ricerca RNA editing, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy 
RNA editing is a widespread epigenetic mechanism in which primary transcripts are modified at 
specific positions. It occurs in a variety of organisms including human and cooperates with 
alternative splicing in increasing both proteomic and transcriptomic complexity. RNA Editing 
can modulate gene expression and lead to altered protein functionality. Indeed, its deregulation 
in human has been linked to several neurological diseases. To date many editing events have 
been identified by next generation sequencing technologies employing massive transcriptome 
and genome sequencing. While this is the optimal way to detect edited positions, genome and 
transcriptome reads from single human individuals are not always available. In contrast, 
numerous RNA-Seq experiments are stored in public databases and represent a relevant source 
of yet unexplored RNA editing sites. 
To identify de novo RNA editing sites in RNA-Seq data we developed an easy computational 
strategy based on a double mapping procedure in which millions of short reads were 
independently mapped onto the human transcriptome and the reference human genome, 
retaining only concordant alignments for downstream analyses. Mapped reads were explored to 
calculate the empirical probability to observe a substitution. Such probabilities were then used 
to detect statistically significant base conversions by applying the Fisher’s exact test by 
comparing the observed and expected occurrences in the aligned reads. 
Applying our double mapping procedure on the SRA study SRA012427 from human brain we 
found 19 highly significant A-to-I conversions in known human coding regions. Interestingly, 11 
of such changes have been already described in literature and 6 were experimentally confirmed 
by Sanger sequencing. We further corroborated our strategy in human spinal cord performing a 
RNA-Seq experiment in which we confirmed 12 out of 15 RNA editing candidates by whole 
exome sequencing carried out on the same individual and tissue. 
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Adolescent THC exposure influences chromatin remodeling 
P. Prini, E. Zamberletti, S. Speziali, M. Gabaglio, T. Rubino, D. Parolaro 
Dept DISTA, Univ. of Insubria, Busto Arsizio (VA) 
We recently demonstrated that adolescent THC treatment triggers the development of a 
complex depressive-like phenotype in adult female rats. Since recent evidence suggests that 
epigenetic mechanisms may underlie the development of mental illnesses, in the present study 
we checked whether epigenetic alterations could underlie the THC-induced depressive-like 
phenotype. 
To this aim, female rats were treated with increasing doses of THC during adolescence (PND 
35-45). Twenty-four hours after the last THC injection, acetylation of Lysin14 and tri-
methylation Lysin27 levels, both on histone H3, were investigated in the PFC, NAc, Hippo and 
Amy, some of the brain areas more involved in the modulation of emotional behavior. 
To clarify whether adolescence really represents a more vulnerable period for the long-term 
adverse effect of THC, the same treatment protocol and subsequent biochemical analyses were 
performed at adulthood (PND 75-85). 
Adolescent THC exposure significantly increased H3K14Ac levels in all the areas considered, 
without altering H3K27-3met levels. In contrast, adult THC exposure only altered H3K14Ac in 
NAc, whereas a significant decrease in H3K27-3met levels was present in the PFC. 
These results suggest that THC exposure triggers different epigenetic alterations depending on 
the time window of administration. Interestingly, adolescent exposure promotes gene 
transcription through an increase of H3K14Ac levels. 
In order to provide information about the genes whose transcription was altered by adolescent 
THC exposure, we measured mRNA levels of the cannabinoid CB1 receptor and some genes 
involved in brain development (i.e. PSD95, BDNF and CREB). 
In the PFC, both CB1 and PSD95 mRNA were significantly enhanced, whereas no changes were 
found in BDNF and CREB mRNA. 
These data indicate that THC treatment triggers different epigenetic modifications in adolescent 
and adult animals. These preliminary data suggest that adolescent THC-induced chromatin 
alterations impact mRNA expression of genes involved in brain development. 
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Genome-wide analysis of chromatin Poly-ADP-Ribosylation in Drosophila melanogaster 
A. Sala1,2, D.F.V. Corona1,2 
1Dulbecco Telethon Institute c/o 2Univ. degli Studi di Palermo, Dipartimento STEMBIO, Sezione Biologia Cellulare, 
Palermo, Italy 
Poly-ADP-Ribosylation is a post-translational modification of proteins mediated by Poly-ADP- 
Ribose Polymerases (PARPs). Using NAD+ as a substrate, PARPs catalyze the covalent 
attachment of ADP-ribose units on target proteins, to generate long linear and branched Poly-
ADP-Ribose (PAR) chains. PARPs are involved in the regulation of critical cellular functions, 
including transcriptional regulation. 
While it is widely demonstrated the accumulation of PAR at decondensed and transcriptionally 
active loci of highly inducible genes, very little is known about basal PARylation function in 
transcription in the absence of induced stimuli. 
Unlike mammals, which have several PARP encoding genes, the model organism 
D.melanogaster has only one PARP gene, highly related to mammalian PARP-1, making flies a 
great model system to study PARP biology. In order to study the role of PARylation on 
chromatin in non-induced conditions we conducted a genome−wide analysis of PAR 
distribution on Drosophila chromosomes. 
Our analisys revealed that PAR has ~5600 high affinity chromatin binding sites, both in genic 
and intergenic regions. In order to check if PAR binds a particular group of genes involved in 
specific biological processes, we conducted an analysis of PAR-bound genes based on their Gene 
Ontology (GO) classification. This GO analysis revealed that PAR binds genes encoding for 
factors involved in a variety of essential biological functions and that PAR-bound genes were 
over represented in genes encoding factors involved in “Signal Transduction”. 
Moreover, in order to identify genes whose expression is altered when the in vivo amount of 
PAR is modified and to correlate ChIP-chip binding data with expression data I carried out 
Drosophila whole-genome expression microarray analysis.  
  SIBBM Seminar | Frontiers in Molecular Biology 
 
 — 69 — 
 
P35 
Differential effects of Ha-RasG12V, Ki-RasG12V and Ki-RasG13D on cell proliferation 
M.R. Saladino, F. Miranda, I. Albanese 
Dipartimento di Scienze e Tecnologie Molecolari e Biomolecolari (STEMBIO), Univ. di Palermo 
Although differing only for the last 24 aminoacids, the three major isoforms of p21 Ras (Ha-, Ki- 
and N –Ras) can trigger alternative pathways of signal transduction, at least in part as a 
consequence of different post-translational modifications and subcellular localization. Ras 
mutations are a common event in tumorigenesis. In colorectal carcinomas (CRCs) the mutations 
affect almost exclusively Ki-Ras, while Ha-Ras mutations are mostly found in bladder 
carcinomas and N-Ras mutations in leukemia cells. In almost all cases, the genetic alteration is a 
point mutation in codons 12 or 13, and less frequently in codon 61. By affecting the GTPase 
activity of the protein, they always lead to a constitutively active protein. However, data obtained 
in different experimental systems or by analysis of primary and metastatic tumors show that 
mutations in different codons, different mutations in the same codon, and mutations of different 
isoforms of Ras may have diverse biological consequences. To shed more light on the molecular 
mechanisms responsible for the different effects of Ras mutations, we have obtained stable 
clones of HT-29 (a human colorectal adenocarcinoma cell line in which the endogenous Ras 
genes are wild type) transfected with cDNAs codifying Ha-RasG12V, Ki-RasG12V and Ki-
RasG13D, under the control of an hormone-inducible promoter. The expression of each of these 
mutated Ras isoforms induces specific, different effects on cell morphology and growth rate. 
FACS analysis shows also a differential effect on the cell cycle. H-RasG12V expression, in 
addition, seems to determine apoptosis. Despite these differences, all three mutated isoforms of 
Ras increase the expression of the CDK inhibitor p21. Preliminary data reveal epigenetic 
changes in the p21 promoter region upon induction of H-RasG12V expression. 
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Replication-independent expression of H1˚ and H3.3 histone variants is probably regulated 
by different RNA-binding proteins 
P. Saladino1, C.M. Di Liegro1, P. Proia2, G. Schiera1, I. Di Liegro3 
Depts of 1Scienze e Tecnologie Molecolari e Biomolecolari, 2Studi Giuridici, Economici, Biomedici, 
Psicosociopedagogici delle Scienze Motorie e Sportive, and 3Biomedicina Sperimentale e Neuroscienze Cliniche, 
Univ. of Palermo, Palermo, Italy 
DNA in eukaryotes is wrapped around core histones to form nucleosomes, the basic units of 
chromatin. The linker histones H1 bind DNA where it enters and leaves the nucleosome, thus 
stabilizing higher order structures. Chromatin is a dynamic complex, modulated by different 
processes such as DNA-methylation, post-translational modifications of histones, and 
incorporation of specific histone variants. Throughout rat brain development, expression of H1° 
and H3.3 histone variants is mainly regulated at the post-transcriptional level. These proteins 
are of interest for their possible involvement in the replication-independent chromatin 
remodelling induced by extracellular stimuli. 
We previously cloned two cDNAs encoding, respectively, PIPPin (or CSD-C2), a brain-enriched 
protein able to bind the 3’end of both H1° and H3.3 mRNAs, and LPI (longer isoform of PEP-
19). Both PEP-19 and LPI are brain-specific. By western blot, we found that PIPPin expression in 
PC12 cells is enhanced by NGF-induced differentiation. We investigated the RNA-binding 
properties of the three proteins using their 6 histidine-tagged recombinant fusions and found 
that they all bind H1° and H3.3 RNAs. Since PEP-19 and LPI are camstatins, we also analyzed 
whether calmodulin could interfere with RNA-binding, and found that calmodulin competes 
with H1° RNA binding to both proteins, while it is not able to bind RNA on its own. This finding 
suggests that, in the brain, PEP19 and LPI could induce histone mRNA translation in response 
to calcium. 
By using biotinylated H1°/H3.3 RNA as fishing molecules, we isolated by affinity 
chromatography a group of proteins which were analyzed by mass spectrometry. Among them 
some heterogeneous nuclear ribonucleoproteins (HnRNP K, A1, A2/B1) and the Hsc70 
chaperone. We are currently studying the interactions among these proteins by co-
immunoprecipitation assays. 
Castiglia D. et al. (Biochem Biophys Res Commun 218: 390-41996) 
Scaturro M. et al. (1998) J Biol Chem 273: 22788-91 
Nastasi T. et al. (1999) J Biol Chem 274: 24087-93 
Sala A et al. (2007) Int J Mol Med 19: 501-9 
Saladino P. et al. (2012) Int J Mol Med 29:141-5 
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Role of microbiota in development, differentiation and epigenetic modifications of model 
organism D. melanogaster 
R. Sanfilippo1,2, S. Campora2, A. M. Puglia2, R. Alduina2, A.Cuomo3, T. Bonaldi3, T. Vaccari4,  
D. Corona1,2 
1Dulbecco Telethon Institute c/o 2STEMBIO Dept, Univ. of Palermo, Italy 
3Dept of Molecular Oncology, European Institute of Oncology, Milano, Italy 
4IFOM – FIRC Institute of Molecular Oncology, Milano, Italy 
The transcriptional status of a gene is tightly linked to the structure of its chromatin. The N-
termini of the four core histones protrude out of nucleosome, making them available for a 
variety of covalent post-translational modifications: specific docking sites for proteins regulating 
chromatin structure and gene transcription that account for the “histone-code”. 
Despite data concerning the ability of some pathogens to manipulate host gene expression by 
modulating chromatin accessibility, relatively little is known about the role of the resident 
Microbiota. 
Using both conventionally reared as well as germ-free D. melanogaster as a model, it was 
demonstrated the involvement of such bacteria in host protein expression and development. 
The aim of this PhD project is to clarify the molecular mechanisms underlying these differences. 
SILAC metabolic labeling and mass spectrometry analysis will be used to recognize differentially 
expressed proteins. 
Using both genetic and biochemical approaches, differentially expressed genes coding for those 
proteins will be identified and their epigenetic modifications will be studied. Furthermore the 
bacterial strain able to modulate host gene expression will be detected through germ-free flies 
colonization experiments. These findings will provide crucial insights into the correlation 
between Drosophila microbiome activity and host metabolic homeostasis. 
Palermo | 24-26 May 2012 
 
 — 72 — 
P38 
A novel Oct4-Rb1 axis is orchestrated by miR-335 to control mESC self-renewal and 
differentiation 
S. Schoeftner1,2,†, M. Scarola1,2, E. Comisso1,2, C. Schneider1,3, R. Benetti1,2,3 
1Laboratorio Nazionale Consorzio Interuniversitario Biotecnologie (LNCIB); Area Science Park; Padriciano 99, 
Trieste, Italy 
2Laboratorio Nazionale Consorzio Interuniversitario Biotecnologie (LNCIB), Oncoepigenetic Unit, Area Science 
Park, Padriciano, Trieste, Italy 
3Dipartimento di Scienze Mediche e Biologiche, Università degli Studi di Udine, Udine, Italy 
†current address: Italian National Cancer Institute, Regina Elena, Rome, Italy  
The pluripotency of mouse embryonic stem cells (mESC) is controlled by a complex network of 
transcription factors, miRNAs and signaling pathways. Here, we provide evidence for a new 
regulatory circuit that connects miR-335, Oct4 and the Retinoblastoma pathway to control 
mESC self-renewal and differentiation. We found that Oct4 drives the expression of Nipp1 and 
Ccnf that inhibit the activity of the protein phosphatase 1 (PP1) complex to ensure hyper-
phosphorylation of the Retinoblastoma protein 1 (pRb) as a key feature of rapidly proliferating, 
self-renewing mESCs. This introduces the Oct4/Nipp1/Ccnf/PP1/Rb1 axis as a novel pathway 
that promotes mESC self-renewal. Importantly, miR-335 can interfere with this regulatory 
circuit by targeting conserved sequence motifs in the 3’UTR of Oct4 and Rb1. The robust 
upregulation of miR-335 upon induction of mESC differentiation co-operates with the 
transcriptional repression of Oct4 to facilitate the collapse of the Oct4/Nipp1/Ccnf/PP1 axis, 
resulting in pRb de-phosphorylation, the exit from self-renewal and the establishment of a pRb 
regulated cell cycle program of differentiated cells. In line with this model, ectopically increased 
miR-335 levels impair self-renewal and accelerate mESC differentiation - preferentially towards 
mesoderm. Our results introduce Oct4 dependent control of the Rb pathway as novel regulatory 
circuit regulating mESC self-renewal and differentiation. 
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Mechanisms of altered transcriptional regulation in the pathogenesis of AEC syndrome 
G. Ferone1,2, A. Sirico1, C. Missero1,2 
1CEINGE BiotecnologieAvanzate, Napoli, Italy 
2Fondazione IRCCS SDN, Napoli, Italy 
The p53 homologue p63 is a tetrameric transcription factor with a pivotal role in stratified 
epithelial development and maintenance. Heterozygous mutations in p63 cause at least five 
closely-related inherited disorders, among which Ankyloblepharon-Ectodermal dysplasia-
Clefting (AEC) syndrome is characterized by severe involvement of the skin. To elucidate the 
molecular mechanisms underlying this disorder, we previously generated a knock-in mouse 
model (p63+/L514F) carrying a clinically relevant missense mutation in the carboxyl-terminal 
region of the p63α isoform, in which AEC mutations are clustered. p63+/L514F mice are affected by 
cleft palate, skin hypoplasia and ectodermal dysplasia, thus faithfully recapitulating the 
phenotype observed in AEC syndrome. Cleft palate and skin hypoplasia are caused by 
hypoproliferation of epithelial progenitors and reduced number of epidermal stem cells 
associated with downregulation of FGF signalling and FGFR2 expression. 
Mechanistically we find that mutant p63L514F protein retains the ability to form tetramers with 
itself and the wild-type protein, however the tetramer has an impaired transactivation activity. 
In mutant cells reduced transactivation is associated with partially impaired p63 binding to DNA 
in the chromatin context and a modest impairment of tri- and di-methylation of histone H3 at 
lysine 4 at the p63 binding sites. Consistently, in the absence of the wild-type protein, p63L514F 
is severely impaired in its ability to bind DNA in the genomic context and is unable to 
transactivate its target genes. These findings indicate that mutant p63 acts in a dominant-
negative fashion affecting p63 ability to transactivate crucial targets in epidermal development. 
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Role of the chromatin remodeling factor ISWI in the Drosophila germline stem cells 
identity 
M. Toto1,2, D.F.V. Corona1,2 
1Dulbecco Telethon Institute c/o 2 Univ. degli Studi di Palermo, Dipartimento STEMBIO, Sezione Biologia 
Cellulare, Palermo, Italy 
The balance between stem cell self-renewal and differentiation is precisely controlled to ensure 
tissue homeostasis as well as to prevent tumorigenesis. Regulation of stemness, which depends 
on both tissue-specific transcriptional regulation and chromatin organization modulation, is still 
poorly understood. It has been shown that in Drosophila ovary, the evolutionary conserved 
chromatin remodeling factor ISWI maintains germ stem cell (GSC) identity repressing the 
expression of the differentiation-promoting bag of marbles (bam) gene. Interestingly, we showed 
that loss of ISWI function in bam mutant female GSCs suppresses the hyperproliferation of 
GSCs tipically observed in a bam mutant ovary, suggesting a role of ISWI in maintaining GSC 
self-renewal in bam-indipendent way. To dissect ISWI role in controlling stem cell self-renewal 
we screened for mutantions in genes that modify ISWI GSC defects. Our study identified two 
evolutionary conserved genes tramtrack and effete capable of suppressing the defects observed 
in ISWI mutant GSCs. These results underline that the mechanism by which ISWI controls GSC 
self-renewal and proliferation do not dependent exclusively on bam but can be influenced by a 
variety of nuclear factors that modulate ISWI chromatin remodeling activity.  
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HIV-Tat interaction with NFkB signaling: upregulation of pro-inflammatory genes 
expression 
E. Vecchio, G. Fiume, A. de Laurentiis, F. Trimboli, C. Palmieri, C. Falcone, F.Fasanella Masci, 
M. Pontoriero, G.Scala, I. Quinto 
Dept of Experimental and Clinical Medicine, Univ. of Catanzaro “Magna Graecia”, Germaneto-Catanzaro, Italy 
Background: Enhanced NFkB activity is present in HIV-1-infected cells leading to up-regulation 
of NFkB-dependent expression of pro-inflammatory genes. We investigated whether the HIV-1 
Tat transactivator sustains the NFkB activity by deregulating the post-activation turn-off of 
NFkB, which is mainly dependent on the de novo synthesis of the IkBa repressor. 
Results: Tat inhibited the post-activation turn-off of NFkB in single round infection of Jurkat 
cells with HXB2-env-pseudotyped HIV-1 virions, as well as in PMA-stimulated HeLa cells 
transfected with Tat. In PMA-stimulated HeLa cells, Tat bound to IkBa and promoted the 
release of p65 from the complex with IkBa. Moreover, Tat counteracted the IkBa inhibition of 
p65 DNA binding and transcriptional activities as shown by EMSA and transient expression 
assays with the kB-Luc reporter. The cysteine-rich domain of Tat and the Rel Homology 
Domain of p65 (1-121 aa) were involved in physical interaction of the two proteins. A further 
analysis of Tat action on multiple gene expression revealed a strong induction of MIP1a 
expression in Tat-transfected HeLa cells, which was mediated by p65. ChIP analysis showed the 
recruitment of p65 at the level of selected NFkB enhancers in Tat-transfected cells, and the Tat 
occupancy of selected NFkB-dependent promoters concomitantly with the IkBa removal from 
the same sites. Conclusions: Based on this study, Tat hijacks the IkBa inhibitor and associates 
with p65 to increase and sustain the NFkB activity. The cross talk of Tat with the NFkB pathway 
here described suggests novel therapeutic strategies for counteracting the Tat and NFkB-
dependent abnormal inflammatory response in AIDS. 
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P2 receptors influence human adipose tissue derived mesenchymal stem cells 
differentiation towards endothelial and smooth muscle cells 
Y. Zhang, D. Khan, M. Lange, A. Pansky, E. Tobiasch 
Dept Natural Science, Bonn-Rhine-Sieg Univ. of Applied Science, Rheinbach, Germany 
Beside the differentiation potential into adipogenic, osteogenic and chondrogenic cell lineages, 
human adipose tissue derived-mesenchymal stem cells (hATSCs) have also shown the ability to 
differentiate towards endothelial cells (ECs) or smooth muscle cells (SMCs) recently, which 
attracted increased attention for the use of hATSCs in vascular system for Regenerative 
Medicine. 
P2 receptors are an old evolutionary but newly characterized family of membrane receptors 
binding ATP, UTP or their breakdown products as ligands. They were play an important role in 
vascular activities. Our recent publication has shown that P2 receptors influence adipogenic and 
osteogenic differentiation of hATSCs. 
In this study, the influence of purinergic signaling on the differentiation process of hATSCs 
towards ECs and SMCs were investigated and verified via RT-PCR, Western blot and 
immunochemical staining with EC and SMC specific markers. P2 receptors not only were 
presented in undifferentiated and differentiated cells, but also show a strongly regulated 
expression level for various types of the purinergic receptors. These expression levels seem to 
have intensively linked to the differentiation process, similar to influence of these receptors 
during the differentiation process towards the osteogenic and adipogenic lineage. 
Here we show for the first time that P2 receptors are a major factor in regulating hATSCs 
differentiation towards ECs and SMCs, which gives new insight in the mesenchymal stem cell 
(MSC) differentiation processes and might be utilized for controlling the MSC fate in the future. 
Correspondence: edda.tobiasch@h-brs.de 
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Role of specialized DNA polymerases in promoting survival of tumor 
E. Zucca1, G. Dianov2, G. Maga1 
1Institute of Molecular Genetics IGM-CNR,  Pavia, Italy 
2Gray Institute for Radiation Oncology & Biology, Univ. of Oxford, United Kingdom 
Specialized DNA polymerases are required for translesion synthesis (TLS) to bypass DNA 
damage lesions. Their over-expression or increased activity, however, could also result in 
enhanced TLS capability, allowing cancer cells to better cope with the high environmental 
stress. The biological significance of deregulation of the DNA repair and TLS pol λ in human 
cancer cells is an open question, so its expression in response to different stress conditions and 
at different cell transformation steps was tested. We confirmed that pol λ expression is induced 
by oxidative damage and DNA strand breaks, but the new emerged feature was that pol λ seems 
to be required for the normal progression through the S-phase. Transient knockdown with 
RNAi and an inducible knockdown cell line of pol λ were used to check the effects of pol λ 
impairment on cell vitality and stress response ability. Flow cytometry analysis of DNA content 
highlighted an S-phase delay in pol λ deficient cells, confirmed by an increase in Chk1 and γ-
H2AX  phosphorylation, that may be due to accumulation of DNA damage. Replicative stress 
due to HU treatment and checkpoint inhibition by UCN-01, showed significant differences 
between knockdown and pol λ-proficient cells, suggesting a possible replication-coupled repair 
mechanism driven by pol λ. 
Pol λ deficiency, thus, induces the checkpoint activation even without DNA damage. The block 
of S-phase checkpoint by UCN-01 in the presence of pol λ knockdown and replication stress due 
to HU promotes a 75% of cell mortality during the next cell cycle. 
In our proposed model, accumulated DNA damage due to HU treatment in pol λ-deficient cells 
cannot be repaired if checkpoint activation is inhibited by UCN-01, leading to cell death. 
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